https://www.pharmacypracticenews.com/Monographs-and-Whitepapers/Article/09-24/-TEMP-TITLE/75023
https://www.pharmacypracticenews.com/Operations-and-Management/Medication-Safety/Article/06-24/Kienles-10-Building-Blocks-Of-Compounding-Safety-for-2024/73813
https://www.pharmacypracticenews.com/Operations-and-Management/Article/06-24/Put-the-Right-Hood-In-Choosing-the-Best-BSCs/73811
https://www.pharmacypracticenews.com/Operations-and-Management/Article/06-24/Strategies-for-Effective-503B-Partnerships/73807
https://www.pharmacypracticenews.com/Operations-and-Management/Article/06-24/The-Road-to-Better-Standardization-In-Cleanroom-Ops/73812
https://www.pharmacypracticenews.com/Operations-and-Management/Article/06-24/7-Tips-for-Meeting-The-Joint-Commissions-Sterile-Compounding-Requirements-in-2024/73809
https://www.pharmacypracticenews.com/Clinical/Oncology/Article/06-24/Sussing-Out-a-2nd-Cancer-Signal-for-CAR-T-Therapy/73906
https://www.pharmacypracticenews.com/Clinical/Oncology/Article/06-24/Pediatric-Cancer-Treatment-Hampered-by-Sparse-Trial-Data/73907
https://www.pharmacypracticenews.com/Opinion/Article/06-24/Addressing-the-Decline-in-Graduating-Pharmacists-The-Role-of-Artificial-Intelligence-and-Automation/74011
https://www.pharmacypracticenews.com/Clinical/Article/06-24/Overview-of-Long-Acting-Injectable-Schizophrenia-Medications/74012
https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/06-24/Sagent-Voluntarily-Recalls-Lots-of-Docetaxel-Injection/74019
https://www.pharmacypracticenews.com/Online-First/Article/06-24/Centralized-Pharmacy-Technicians-Streamline-Prior-Authorizations/74028
https://www.pharmacypracticenews.com/Covid-19/Article/06-24/Federal-Retail-Pharmacy-Program/74029
https://www.pharmacypracticenews.com/Online-First/Article/06-24/Using-IA-Improves-Medication-Safety-Quality-of-Care/74027
https://www.pharmacypracticenews.com/Online-First/Article/06-24/Embedded-Specialty-Pharmacist-Improves-Therapy-Access-in-Dermatology-Clinic/74033
https://www.pharmacypracticenews.com/Operations-and-Management/Article/06-24/Alexa-Can-You-Tell-Me-About-My-Meds/74031
https://www.pharmacypracticenews.com/FDA-News/Article/06-24/RSV-Vaccine-Adults-50-59/74065
https://www.pharmacypracticenews.com/Online-First/Article/06-24/Becoming-a-Prime-Employer-and-Other-Pharmacist-Recruitment-Strategies/74056
https://www.pharmacypracticenews.com/Online-First/Article/06-24/Missing-Information-Causes-Most-Miscommunication-Related-Medication-Events/74069
https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/06-24/FDA-Grants-Traditional-Approval-to-Retevmo-for-RET-Fusion-Positive-Thyroid-Cancer/74086
https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/06-24/Augtyro-Approved-for-Adult-and-Pediatric-Patients-With-NTRK-Gene-Fusion-Positive-Solid-Tumors/74087
https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/06-24/FDA-Approves-Keytruda-With-Chemo-for-Primary-Advanced-or-Recurrent-Endometrial-Carcinoma/74102
https://www.pharmacypracticenews.com/Clinical/Oncology/Article/06-24/Sexual-Dysfunction-Common-for-Women-With-MBC/73910
https://www.pharmacypracticenews.com/Policy/Article/06-24/Bill-for-Home-Infusion-Benefit-Still-Awaiting-Congressional-Score/73909
https://www.pharmacypracticenews.com/People-in-Pharmacy/Article/06-24/Pharmacist-Scribes-Mission-Correcting-Drug-Details-in-Plots/73908
https://www.pharmacypracticenews.com/Clinical/Medication-Safety/Article/06-24/Safety-Risks-Beyond-the-Pharmacy-Walls/73919
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/06-24/Smishing-Cyberattacks-Hook-Personal-Data/73918
https://www.pharmacypracticenews.com/Clinical/Nutrition/Article/06-24/Addressing-Exocrine-Insufficiencies-in-Pancreatitis-Patients/73917
https://www.pharmacypracticenews.com/Online-First/Pulmonology/Article/06-24/Weight-Loss-Drug-Could-Cure-Sleep-Apnea-in-Up-to-Half-of-Obese-Patients/74139
https://www.pharmacypracticenews.com/Policy/Generics/Article/06-24/The-High-Shortage-Generic-Market/73915
https://www.pharmacypracticenews.com/Policy/Biosimilars/Article/06-24/Biosimilars-Gain-a-Foothold-in-Challenging-Market/73914
https://www.pharmacypracticenews.com/Policy/Article/06-24/CMS-Incentivizes-Payor-Health-Disparity-Performance/73913
https://www.pharmacypracticenews.com/Policy/Biosimilars/Article/06-24/Canada-Puts-a-Chill-in-Biosimilar-Switches/73912
https://www.pharmacypracticenews.com/Clinical/Oncology/Article/06-24/Palliative-Cancer-Care-Often-Poses-Ethical-Dilemmas/73911
https://www.pharmacypracticenews.com/FDA-News/Infectious-Diseases/Article/06-24/FDA-Approves-Capvaxive-Pneumonia-Vaccine/74142
https://www.pharmacypracticenews.com/Clinical/Oncology/Article/06-24/How-Supportive-and-Palliative-Oncology-Partnerships-Provide-Lifesaving-Answers/74146
https://www.pharmacypracticenews.com/Clinical/Oncology/Article/06-24/Latest-DREAMM-Trial-Suggests-Potential-Standard-for-Relapsed-Multiple-Myeloma/74147
https://www.pharmacypracticenews.com/Policy/Article/06-24/ACIP-Vaxelis-for-American-Indian-Alaska-Native-Infants/74157
https://www.pharmacypracticenews.com/Online-First/Article/06-24/ACIP-RSV-Vaccine/74158
https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/06-24/FDA-Grants-Accelerated-Approval-to-Epkinly-for-Relapsed-or-Refractory-Follicular-Lymphoma/74162
https://www.pharmacypracticenews.com/Covid-19/Article/06-24/ACIP-Recommends-2024-25-COVID-19-Vaccination-for-Ages-6-Months-and-Older/74171
https://www.pharmacypracticenews.com/FDA-News/Article/07-24/FDA-Clears-bioM-rieux-Biofire-Spotfire-R-ST-Panel-and-AST-System-Vitek-Reveal/74210
https://www.pharmacypracticenews.com/Clinical/Nutrition/Article/07-24/Solving-the-Nutrition-Drug-Interactions-Puzzle/74193
https://www.pharmacypracticenews.com/FDA-News/Article/07-24/FDA-Approves-Pyzchiva-Biosimilar-to-Stelara/74227
https://www.pharmacypracticenews.com/FDA-News/Article/07-24/FDA-Approves-Kisunla-to-Treat-Early-Alzheimers-Disease/74229
https://www.pharmacypracticenews.com/Policy/Article/07-24/Influenza-Vaccines-Solid-Organ-Transplants/74230
https://www.pharmacypracticenews.com/Monographs-and-Whitepapers/Article/07-24/RFID-Medications/74234
https://www.pharmacypracticenews.com/Clinical/Women’s-Health/Article/07-24/Low-Dose-Aspirin-May-Prevent-Pregnancy-Complications-Related-to-Flu/74258
https://www.pharmacypracticenews.com/Online-First/Oncology/Article/07-24/Large-Data-Set-Sheds-Light-on-Rate-of-CAR-T-Side-Effects/74261
https://www.pharmacypracticenews.com/Monographs-and-Whitepapers/Article/07-24/Use-of-Dalbavancin-in-Optimizing-the-Management-of-ABSSSIs-in-Patients-With-Obesity-or-Diabetes/74265
https://www.pharmacypracticenews.com/Covid-19/Article/07-24/Federal-Retail-Pharmacy-Program/74292
https://www.pharmacypracticenews.com/Industry-News/Article/07-24/Sanofi-Ships-U-S-Influenza-Vaccines-for-2024-2025-Season/74293
https://www.pharmacypracticenews.com/Operations-and-Management/Article/07-24/Prime-Employer-One-Of-Many-Recruitment-Pearls-at-ASHP-Futures/74195
https://www.pharmacypracticenews.com/Online-First/Article/07-24/Meningococcal-Disease-Umrah-Pilgrimage-Risk/74310
https://www.pharmacypracticenews.com/Operations-and-Management/Hematology/Article/07-24/CGTs-a-Big-Deal-for-Pharmacy-So-Getting-Payment-Right-Is-Crucial/74194
https://www.pharmacypracticenews.com/Policy/Article/07-24/Staying-on-Top-of-FY-2025-Payment-Rules/74198
https://www.pharmacypracticenews.com/Online-First/Article/07-24/RSV-Vaccine-Safety-Findings/74334
https://www.pharmacypracticenews.com/Industry-News/Article/07-24/FDA-Approves-Long-Groves-Premix-Vasopressin/74346
https://www.pharmacypracticenews.com/FDA-News/Article/07-24/FDA-Approval-Vonoprazan-NERD/74352
https://www.pharmacypracticenews.com/Industry-News/Article/07-24/Hardy-Diagnostics-Releases-Enrichment-Broth-for-C-auris-Detection/74341
https://www.pharmacypracticenews.com/Online-First/Article/07-24/HIV-Cure-Next-Berlin-Patient/74371
https://www.pharmacypracticenews.com/Operations-and-Management/Article/07-24/Centralized-Pharmacy-Technicians-Streamline-Prior-Authorizations/74196
https://www.pharmacypracticenews.com/Online-First/Article/07-24/DTG-3TC-Virologic-Suppression-HIV/74376
https://www.pharmacypracticenews.com/Industry-News/Article/07-24/Blood-Culture-Media-Bottles-in-Short-Supply/74377
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Medication-Safety/Article/07-24/New-Tech-Brings-Home-Infusion-to-the-Cloud/74205
https://www.pharmacypracticenews.com/Online-First/Article/07-24/Lenacapavir-100-Efficacy-PrEP/74394
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/07-24/Alexa-Can-You-Tell-Me-About-My-Meds/74207
https://www.pharmacypracticenews.com/Operations-and-Management/Endocrinology/Article/07-24/Report-GLP-1-Adherence-Rates-Lower-Than-Expected/74208
https://www.pharmacypracticenews.com/Online-First/Article/07-24/Cabenuva-Adolescents-Virologically-Suppressed/74399
https://www.pharmacypracticenews.com/Operations-and-Management/Article/07-24/Report-Unjustified-Insurance-Denials-Frequently-Delay-Timely-Care/74209
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Medication-Safety/Article/07-24/IV-Syringe-Robots-Not-Plug-and-Play/74206
https://www.pharmacypracticenews.com/Operations-and-Management/Article/07-24/Filling-the-DEI-Gap-in-EHR-Notes-and-Clinical-Trials/74204
https://www.pharmacypracticenews.com/Policy/Article/07-24/503Bs-and-Their-Role-in-Responding-to-Drug-Shortages/74197
https://www.pharmacypracticenews.com/Industry-News/Article/07-24/Students-Learn-About-Healthcare-Careers-at-Swisslog-Healthcare/74410
https://www.pharmacypracticenews.com/Clinical/Nutrition/Article/07-24/When-Feeding-ICU-Patients-Make-It-Personal/74199
https://www.pharmacypracticenews.com/Operations-and-Management/Medication-Safety/Article/07-24/Missing-Information-a-Top-Cause-of-Medication-Events/74203
https://www.pharmacypracticenews.com/Clinical/Oncology/Article/07-24/Resolving-CAR-T-Complications-in-the-ICU/74202
https://www.pharmacypracticenews.com/Clinical/Nutrition/Article/07-24/Malnutrition-Is-Endemic-to-IBD-but-Can-Be-Managed/74200
https://www.pharmacypracticenews.com/Online-First/Article/07-24/Gummies-Containing-Psychedelic-Mushrooms-Cause-Harm/74429
https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/07-24/FDA-Approves-Darzalex-Faspro-With-Bortezomib-Lenalidomide-and-Dexamethasone-for-Multiple-Myeloma/74443
https://www.pharmacypracticenews.com/Clinical/Pharmacogenomics/Article/07-24/PGx-Promising-for-Psychiatry-but-no-Magic-Bullet/74201
https://www.pharmacypracticenews.com/Policy/Article/08-24/One-More-Time-The-Importance-of-Data-Accuracy/74423
https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/08-24/Do-Cefotaxime-Alternatives-Increase-Adverse-Events-in-Neonates/74411
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/08-24/Pharmacy-Groups-Urge-Action-After-Change-Healthcare-Attack/74477
https://www.pharmacypracticenews.com/Industry-News/Article/08-24/Mallinckrodt-Announces-Availability-of-Acthar-Gel-Single-Dose-Pre-filled-SelfJect-Injector/74495
https://www.pharmacypracticenews.com/FDA-News/Hematology/Article/08-24/FDA-Approves-Fibryga-for-Acquired-Fibrinogen-Deficiency/74498
https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/08-24/Voranigo-Approved-for-Astrocytoma-or-Oligodendroglioma-With-a-Susceptible-IDH1-or-IDH2-Mutation/74517
https://www.pharmacypracticenews.com/Policy/Article/08-24/Congratulations-Youre-a-Lab-Considerations-for-Sterile-Media/74412
https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/08-24/Lymphir-Approved-for-Adults-With-Relapsed-or-Refractory-Cutaneous-T-Cell-Lymphoma/74535
https://www.pharmacypracticenews.com/Clinical/Nutrition/Article/08-24/Strategies-for-Managing-Nutritional-Complications-Of-Novel-Cancer-Therapies/74413
https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/08-24/Strong-Weapons-Needed-to-Combat-AMR/74417
https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/08-24/Rising-Rates-of-STIs-Present-Opportunities-for-Intervention/74418
https://www.pharmacypracticenews.com/FDA-News/Immunology/Article/08-24/FDA-Approves-Niktimvo-for-Chronic-Graft-Versus-Host-Disease/74602
https://www.pharmacypracticenews.com/Clinical/GI-Disorders/Article/08-24/alcohol-associated-liver-disease-guidelines-ACG-Loretta-Jophlin-MD-PhD/74617
https://www.pharmacypracticenews.com/Policy/Medication-Safety/Article/08-24/Unregulated-Infusion-Spas-Deemed-Hazardous-Compounders/74616
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/08-24/ASHP-Survey-Adoption-of-Tech-Solutions-Increasing-in-Hospital-Pharmacies/74415
https://www.pharmacypracticenews.com/Policy/Infectious-Diseases/Article/08-24/VFC-Prevented-1-Million-Child-Deaths-in-Its-30-Year-History/74640
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Medication-Safety/Article/08-24/Free-ASHP-Tool-Helps-Identify-Drug-Diversion-Gaps/74656
https://www.pharmacypracticenews.com/Clinical/Nutrition/Article/08-24/Can-Nutritional-Wellness-Keep-Liver-Disease-at-Bay/74421
https://www.pharmacypracticenews.com/FDA-News/Anesthesiology-and-Analgesia/Article/08-24/FDA-Approves-Amneal-Propofol-Injectable-Emulsion-Single-Dose-Vials/74661
https://www.pharmacypracticenews.com/Online-First/Infectious-Diseases/Article/08-24/Viral-Hepatitis-Is-Not-Gone-Not-Yet/74663
https://www.pharmacypracticenews.com/Policy/Article/08-24/So-Youre-the-Designated-Person-What-Does-That-Mean/74422
https://www.pharmacypracticenews.com/FDA-News/Immunology/Article/08-24/FDA-Approval-Seladelpar-Primary-Biliary-Cholangitis/74673
https://www.pharmacypracticenews.com/Clinical/Nutrition/Article/08-24/Parenteral-Nutrition-Medication-Compatibility/74420
https://www.pharmacypracticenews.com/Operations-and-Management/Article/08-24/Rise-in-Drug-Spending-Not-Reflected-in-Hospital-Pharmacies/74419
https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/08-24/Better-Together-Rapid-Diagnostic-Testing-And-Antibiotic-Stewardship/74416
https://www.pharmacypracticenews.com/Clinical/Oncology/Article/08-24/CAR-Ts-and-BiTEs-The-Cost-and-Efficacy-Equation/74414
https://www.pharmacypracticenews.com/Online-First/Article/08-24/Georgia-Hepatitis-Elimination-Model/74666
https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/08-24/MASLD-and-HBV-How-Concurrence-May-Paradoxically-Protect-and-Worsen-Disease/74662
https://www.pharmacypracticenews.com/Operations-and-Management/Article/08-24/For-Successful-WEE-Filing-for-DSCSA-Be-Specific/74727
https://www.pharmacypracticenews.com/Operations-and-Management/Article/08-24/How-to-Ace-Your-FDA-Inspection/74728
https://www.pharmacypracticenews.com/FDA-News/Article/08-24/FDA-Grants-Accelerated-Approval-to-Tecelra-for-Unresectable-or-Metastatic-Synovial-Sarcoma/75521
https://www.pharmacypracticenews.com/Policy/Article/09-24/5-Steps-for-Keeping-Your-CDM-Alive-and-Well/74626
https://www.pharmacypracticenews.com/Covid-19/Infectious-Diseases/Article/09-24/Early-COVID-19-Testing-Might-Miss-Up-to-92-of-Cases/74660
https://www.pharmacypracticenews.com/FDA-News/Infectious-Diseases/Article/09-24/FDA-Approves-Updated-COVID-Vaccines/74678
https://www.pharmacypracticenews.com/Clinical/Article/09-24/Specialty-Pharmacies-Role-in-Gene-Therapy/74721
https://www.pharmacypracticenews.com/Review-Articles/Pulmonology/Article/09-24/Management-of-Pulmonary-Arterial-Hypertension/74722
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Cardiology/Article/09-24/Pharmacist-Managed-Remote-Heart-Failure-Program/74734
https://www.pharmacypracticenews.com/Operations-and-Management/Article/09-24/What-Keeps-Pharmacy-Stakeholders-Up-at-Night/74723
https://www.pharmacypracticenews.com/Clinical/Article/09-24/Why-Health-Plans-Need-a-High-Health-Equity-Index-to-Prosper/74724
https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/09-24/Bictegravir-Lenacapavir-an-Effective-ART-Switch/74744
https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/09-24/Failing-to-Meet-Global-Targets-Means-17-7-Million-More-AIDS-Related-Deaths/74745
https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/09-24/FDA-Approves-Authorizes-Updated-COVID-19-Vaccines/74747
https://www.pharmacypracticenews.com/Policy/Biosimilars/Article/09-24/FDA-Updates-Biosimilars-Action-Plan/74749
https://www.pharmacypracticenews.com/Policy/Article/09-24/Pharmacy-Organizations-Raise-Alarms-on-DSCSA-Preparedness/74740
https://www.pharmacypracticenews.com/Operations-and-Management/Article/09-24/Offsetting-High-Drug-Costs-Is-a-Moving-Target/74750
https://www.pharmacypracticenews.com/Covid-19/Infectious-Diseases/Article/09-24/IDSA-Updates-COVID-19-Treatment-Guidelines-to-Include-Pemgarda/74813
https://www.pharmacypracticenews.com/FDA-News/Infectious-Diseases/Article/09-24/FDA-Committee-Weighs-New-Oral-uUTI-Antibiotic/74830
https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/09-24/DoxyPrEP-Reduces-Bacterial-STIs/74746
https://www.pharmacypracticenews.com/Clinical/Article/09-24/A-Summary-of-Selected-2023-2024-FDA-MedWatch-Alerts/74748
https://www.pharmacypracticenews.com/Clinical/Pharmacogenomics/Article/09-24/PGx-May-Take-Edge-Off-Pain-Management/74743
https://www.pharmacypracticenews.com//GI-Disorders/Article/09-24/guselkumab-tremfya-ulcerative-colitis-approval-FDA/74846
https://www.pharmacypracticenews.com/Clinical/Nutrition/Article/09-24/Feeding-Challenges-in-the-ICU-Avoiding-Necrosis-and-Other-Risks/74741
https://www.pharmacypracticenews.com/Policy/Article/09-24/Juggling-State-Rules-And-Joint-Commission-A-Key-in-2025-Surveys/74742
https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/09-24/FDA-Approves-Tecentriq-Hybreza-for-Subcutaneous-Injection-for-All-Adult-Indications-of-IV-Tecentriq/74859
https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/09-24/Kisqali-With-an-AI-and-Kisqali-Femara-Co-Pack-Approved-for-Early-High-Risk-Breast-Cancer/74874
https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/09-24/FDA-Approves-Keytruda-With-Chemo-for-Unresectable-Advanced-or-Metastatic-Malignant-Pleural-Mesothelioma/74895
https://www.pharmacypracticenews.com/Online-First/Nutrition/Article/09-24/apraglutide-short-bowel-syndrome-GLP-2-drug/74897
https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/09-24/Meningococcal-Cases-Increasing-in-U-S/74906
https://www.pharmacypracticenews.com/FDA-News/Inflammatory-Diseases/Article/09-24/FDA-Approves-Fasenra-for-EGPA/74908
https://www.pharmacypracticenews.com/Online-First/Nutrition/Article/09-24/nutrition-drug-interaction-transplant-patients-liver-transplant/74893
https://www.pharmacypracticenews.com/Online-First/Article/09-24/Atovaquone-Oral-Suspension-Recalled-Due-to-Bacterial-Contamination/74922
https://www.pharmacypracticenews.com/Online-First/Medication-Safety/Article/09-24/Xylazine-Wounds-Opioid-Adulteration-Massachusetts/74903
https://www.pharmacypracticenews.com/Monographs-and-Whitepapers/Article/09-24/Gohibic-trade-vilobelimab-A-Treatment-Option-For-Critically-Ill-COVID-19-Patients/74925
https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/09-24/-FDA-Approves-Rybrevant-for-NSCLC-With-EGFR-Exon-19-Deletions-or-L858R-Mutations/74929
https://www.pharmacypracticenews.com/FDA-News/Article/09-24/Nasal-Spray-Influenza-Vaccine-Approval/74933
https://www.pharmacypracticenews.com/FDA-News/Hematology/Article/09-24/-FDA-Approves-Sarclisa-With-Bortezomib-Lenalidomide-and-Dexamethasone-for-Newly-Diagnosed-Multiple-Myeloma/74930
https://www.pharmacypracticenews.com/Online-First/Oncology/Article/09-24/new-onset-diabetes-pancreatic-cancer-signs/74899
https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/09-24/Tagrisso-Approved-for-Some-With-Locally-Advanced-Unresectable-Stage-III-NSCLC-Following-Chemoradiation/74952
https://www.pharmacypracticenews.com/FDA-News/Article/09-24/FDA-Approved-Levacetylleucine-NPC-Treatment/74957
https://www.pharmacypracticenews.com/Online-First/GI-Disorders/Article/09-24/fecal-microbiota-transplant-UC-upadacitinib-Crohn-s-Miguel-Regueiro/74888
https://www.pharmacypracticenews.com/Compliance/Article/09-24/Whats-Your-EQ-Using-Emotional-Intelligence-in-Sterile-Compounding-Training/74947
https://www.pharmacypracticenews.com/Compliance/Article/09-24/10-Tips-for-Home-Infusion-Accreditation-Inspection/74946
https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/09-24/FDA-Fully-Approves-Retevmo-for-RET-Fusion-Positive-Medullary-Thyroid-Cancer/74997
https://www.pharmacypracticenews.com/Multimedia/Hematology/Article/09-24/heparin-resistance-antithrombin-deficiency-venous-thromboembolism-antithrombin-concentrate/74999
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/09-24/Free-ASHP-Tool-Helps-Identify-Drug-Diversion-Gaps/74770
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/09-24/Pharmacy-Groups-Urge-Action-After-Change-Healthcare-Attack/74773
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/09-24/Pharmacy-Organizations-Raise-Alarm-on-DSCSA/74767
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/09-24/Healthcare-Technology-Pharmacy-Customers/74867
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/09-24/Remote-Patient-Monitoring-Faces-Adoption-Hurdles/74769
https://www.pharmacypracticenews.com/Opinion/Article/09-24/Armageddon-The-Why-to-War-Games/74900
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Medication-Safety/Article/09-24/Fractal-Management-Boosts-Smart-Pump-Safety/74766
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/GI-Disorders/Article/09-24/GLP-1s-responders-AI-picks-ozempic-obesity/74891
https://www.pharmacypracticenews.com/Online-First/Pain/Article/09-24/Telehealth-May-Ease-Some-Stigma-Linked-to-Treatment-for-OUD/74901
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Medication-Safety/Article/09-24/AI-Medication-Management-Atlantic-Health/74768
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/09-24/Focusing-on-the-Final-Link-in-the-Cold-Chain/74780
https://www.pharmacypracticenews.com/Clinical/GI-Disorders/Article/09-24/New-Guideline-for-H-pylori-Changes-Primary-Treatment-Recommendation/74940
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/09-24/Pharmacists-Must-Be-Leaders-in-AI-Development/74779
https://www.pharmacypracticenews.com/Online-First/Hematology/Article/09-24/Sickle-Cell-Drug-Oxbryta-Withdrawn-From-Market/74963
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/09-24/Artificial-Intelligence-Can-Improve-Medication-History/74778
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/09-24/Pharmacy-Graduation-Decline-Concern/74777
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/09-24/AI-Specialty-Pharmacy-Potential/74776
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/09-24/AI-Tools-Pharmacy-Education/74775
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Medication-Safety/Article/09-24/Achieving-Success-With-IV-Room-Verification-Technology/74774
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Medication-Safety/Article/09-24/Preventing-ADC-Medication-Errors/74772
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/09-24/Hospital-Pharmacy-Technology-Solutions/74771
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Cardiology/Article/10-24/Wearable-ECG-Monitoring-Pharmacists-Essential/75041
https://www.pharmacypracticenews.com/Monographs-and-Whitepapers/Article/10-24/Parenteral-Nutrition/75058
https://www.pharmacypracticenews.com/Opinion/Article/10-24/3-Reasons-Why-Pharmacies-and-Labs-Should-Partner/75039
https://www.pharmacypracticenews.com/Online-First/Biosimilars/Article/10-24/Pharmacists-Key-in-Supporting-Biosimilar-Uptake/75062
https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/10-24/FDA-Approves-Neoadjuvant-Adjuvant-Opdivo-for-Resectable-NSCLC/75067
https://www.pharmacypracticenews.com/Policy/Endocrinology/Article/10-24/FDA-and-State-Boards-Eye-GLP-1s-Amid-Larger-Compounding-Scrutiny/75026
https://www.pharmacypracticenews.com/Clinical/Article/10-24/Pharm-Capsules/75038
https://www.pharmacypracticenews.com/Online-First/Article/10-24/Building-a-Temple-to-Better-Specialty-Care/75091
https://www.pharmacypracticenews.com/Online-First/Article/10-24/FDA-Lagging-in-Pharmaceutical-Facility-Inspections-Could-Affect-Drug-Shortages/75096
https://www.pharmacypracticenews.com/Multimedia/Article/10-24/Mitigating-Inequities-Language-is-the-Road-to-Better-Health/75097
https://www.pharmacypracticenews.com/Operations-and-Management/Article/10-24/Conserving-IV-Fluids-Critical-as-Hurricane-Flooding-Damages-Key-Facility/75124
https://www.pharmacypracticenews.com/Online-First/Article/10-24/Biosimilar-Uptake-Remains-Variable-Posing-Challenges-to-the-Market/75127
https://www.pharmacypracticenews.com/Online-First/Article/10-24/-Tail-Period-for-Compounders-Could-Ease-Weight-Loss-Rx-Shortages/75130
https://www.pharmacypracticenews.com/Online-First/Article/10-24/Breathing-New-Life-Into-the-NSCLC-Pipeline/75134
https://www.pharmacypracticenews.com/Online-First/Article/10-24/FDA-Grants-Reprieve-on-Enhanced-DSCSA-Requirements-With-New-Phased-In-Deadlines/75146
https://www.pharmacypracticenews.com/Policy/Article/10-24/NASP-Urges-Action-on-Abysmal-Medicare-Reimbursement/75157
https://www.pharmacypracticenews.com/Monographs-and-Whitepapers/Article/10-24/The-NOPAIN-Act-Clinical-and-Financial-Opportunities-in-Hospital-Outpatient-and-Ambulatory-Settings/75138
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Critical-Care/Article/10-24/Machine-Learning-Can-Aid-in-Sepsis-Identification/75163
https://www.pharmacypracticenews.com/Online-First/Oncology/Article/10-24/Holistic-Oncology-and-Specialty-Pharmacists/75177
https://www.pharmacypracticenews.com/Online-First/Article/10-24/Quantifying-the-Cost-of-Specialty-Pharmacist-Interventions-for-Outside-Prescriptions/75178
https://www.pharmacypracticenews.com/Industry-News/Article/10-24/Premier-and-Long-Grove-Partner-to-Increase-Norepinephrine-IV-Bag-Supply/75184
https://www.pharmacypracticenews.com/Online-First/Pharmacogenomics/Article/10-24/Promise-and-Hurdles-in-Personalized-Medicine/75190
https://www.pharmacypracticenews.com/Clinical/Pharmacogenomics/Article/10-24/Bringing-Diversity-to-Pharmacogenomics/75029
https://www.pharmacypracticenews.com/Operations-and-Management/Article/10-24/Pharmacy-Modernizes-but-Where-Is-Provider-Status/75035
https://www.pharmacypracticenews.com/Online-First/Infectious-Diseases/Article/10-24/Tennessee-HIV-Funding-Rejection-Consequences/75199
https://www.pharmacypracticenews.com/Online-First/Infectious-Diseases/Article/10-24/Pediatric-Antibiotic-Prescribing/75200
https://www.pharmacypracticenews.com/Online-First/Infectious-Diseases/Article/10-24/Late-Diagnosis-Complicates-Chronic-Hepatitis-B/75202
https://www.pharmacypracticenews.com/Online-First/Infectious-Diseases/Article/10-24/Pharmacist-Recommendations-Improve-Hepatitis-B-Screening-in-Oral-Oncology-Patients/75203
https://www.pharmacypracticenews.com/Online-First/Infectious-Diseases/Article/10-24/Proposed-FDA-Rule-Could-Enable-POC-Hepatitis-B-Testing/75206
https://www.pharmacypracticenews.com/Multimedia/Medication-Safety/Article/10-24/Video-Specialty-Pharmacy-Disaster-Plans/75207
https://www.pharmacypracticenews.com/Clinical/Oncology/Article/10-24/Oral-Oncolytics-Adverse-Events-Monitoring/75185
https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/10-24/Vyloy-With-Chemotherapy-Approved-for-Gastric-or-Gastroesophageal-Junction-Adenocarcinoma/75221
https://www.pharmacypracticenews.com/Policy/Article/10-24/FDA-Inspections-Waivers-Amid-Top-Concerns-as-DSCSA-Looms/75223
https://www.pharmacypracticenews.com/Online-First/Article/10-24/Oncology-Pipeline-Exciting-Breakthroughs-Cited-at-AMCP-Nexus-2024/75231
https://www.pharmacypracticenews.com/Online-First/Article/10-24/Rigorous-Real-World-Evidence-Should-Inform-Formulary-Decisions/75232
https://www.pharmacypracticenews.com/Clinical/Oncology/Article/10-24/Expanding-CDK4-6-Inhibitors-to-Early-Stage-Breast-Cancer/75222
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/10-24/Patient-Experience-a-Growing-Target-for-Tech-Solutions/75037
https://www.pharmacypracticenews.com/Online-First/Article/10-24/ACIP-PCV-Vote-50/75242
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Medication-Safety/Article/10-24/Counterfeit-Drugs-Online-Pharmacies/75245
https://www.pharmacypracticenews.com/Online-First/Article/10-24/After-Helene-Damage-FDA-Grants-Compounding-Flexibility-for-IV-Solutions-During-Shortage/75247
https://www.pharmacypracticenews.com/Operations-and-Management/Article/10-24/HSSPs-Avoid-Unnecessary-Costs-Through-Meaningful-Interventions/75036
https://www.pharmacypracticenews.com/Online-First/Article/10-24/After-Latest-DSCSA-Reprieve-Experts-Offer-Tips-for-Navigating-New-Deadlines/75265
https://www.pharmacypracticenews.com/Online-First/Article/10-24/Rapid-Multiplexed-Molecular-Panel/75268
https://www.pharmacypracticenews.com/Policy/Article/10-24/The-Proposed-CY-2025-OPPS-ASC-and-PFS-Payment-Rules/75034
https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/10-24/Pharmacist-Led-HCV-Treatment-Success/75224
https://www.pharmacypracticenews.com/Policy/Medication-Safety/Article/10-24/Mitigating-the-Risks-From-Sudden-Admixture-Shortages/75033
https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/10-24/Twice-Yearly-Lenacapavir-Sets-a-New-PrEP-Standard/75031
https://www.pharmacypracticenews.com/Clinical/Article/10-24/A-History-of-Pharmacy-as-a-Profession/75032
https://www.pharmacypracticenews.com/People-in-Pharmacy/Article/10-24/On-the-Front-Lines-Of-Preparedness-A-Career-in-Pharmacy/75027
https://www.pharmacypracticenews.com/Clinical/Pulmonology/Article/10-24/Biologics-Hit-Multiple-Targets-in-Asthma-and-COPD/75030
https://www.pharmacypracticenews.com/Policy/Article/10-24/Need-a-DSCSA-Pause-Heres-How-to-File-An-Effective-WEE-Form/75028
https://www.pharmacypracticenews.com/Online-First/Article/10-24/CDC-Recommends-Second-Dose-of-2024-2025-COVID-19-Vaccine-for-Older-or-Immunocompromised-People/75310
https://www.pharmacypracticenews.com/FDA-News/Hematology/Article/10-24/Asciminib-Approval-Chronic-Myeloid-Leukemia/75320
https://www.pharmacypracticenews.com/Online-First/Article/10-24/How-a-GLP-1-Shadow-System-Puts-Patients-Safety-at-Risk/75304
https://www.pharmacypracticenews.com/Monographs-and-Whitepapers/Article/11-24/radio-frequency-identification/75204
https://www.pharmacypracticenews.com/Online-First/Article/11-24/Sepsis-Core-Elements-Program-Drives-Improvements/75357
https://www.pharmacypracticenews.com/Online-First/Article/11-24/Webinar-Offers-Guidance-on-Preparing-for-DEA-Diversion-Inspections/75377
https://www.pharmacypracticenews.com/Review-Articles/Article/11-24/Hepatitis-B-and-HIV-Coinfection/75379
https://www.pharmacypracticenews.com/Online-First/Article/11-24/Immigrants-With-Chronic-HBV-Are-Vulnerable-to-Lapses-in-Antiviral-Use/75380
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/11-24/Drug-Information-Specialists-Offer-Practical-Tips-for-Combating-Misinformation/75390
https://www.pharmacypracticenews.com/Online-First/Article/11-24/Ensuring-Hazardous-Drug-Safety-a-Team-Approach/74104
https://www.pharmacypracticenews.com/Online-First/Article/11-24/Tips-for-Easing-the-Sterile-Compounding-Staffing-Crisis/74108
https://www.pharmacypracticenews.com/Policy/Article/11-24/How-to-Avoid-Groundhog-Day-Syndrome-When-Dealing-With-Hazardous-Drugs/75419
https://www.pharmacypracticenews.com/Online-First/Article/11-24/Improving-HBV-Screening-Before-Switching-to-2-Drug-HIV-Regimens/75384
https://www.pharmacypracticenews.com/Operations-and-Management/Article/11-24/After-Latest-DSCSA-Reprieve-Experts-Offer-Tips-for-Navigating-New-Deadlines/75392
https://www.pharmacypracticenews.com/Clinical/Cardiology/Article/11-24/Pharmacists-Key-Players-on-AFib-Treatment-Teams/75396
https://www.pharmacypracticenews.com/FDA-News/Hematology/Article/11-24/FDA-Approves-Aucatzyl-for-Adults-With-Relapsed-or-Refractory-B-Cell-Precursor-ALL/75426
https://www.pharmacypracticenews.com/Clinical/Article/11-24/Pharm-Capsules/75400
https://www.pharmacypracticenews.com/Operations-and-Management/Article/11-24/A-History-of-Pharmacy-as-a-Profession/75416
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/11-24/AI-Poised-to-Improve-Trial-Recruitment-and-Drug-Adherence-in-Specialty-Pharmacy/75447
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/11-24/Is-AI-the-Patient-and-Staff-Support-Program-of-the-Future/75449
https://www.pharmacypracticenews.com/Clinical/Biosimilars/Article/11-24/Biosimilar-Treatment-Inflammatory-Diseases/75397
https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/11-24/Optimal-Antimicrobial-Stewardship/75418
https://www.pharmacypracticenews.com/Operations-and-Management/Article/11-24/Toward-a-More-Environmentally-Sustainable-Cold-Chain/75417
https://www.pharmacypracticenews.com/Operations-and-Management/Article/11-24/Catching-Up-With-Coding-Updates/75415
https://www.pharmacypracticenews.com/Clinical/Biosimilars/Article/11-24/Biosimilar-Uptake-Remains-Variable/75407
https://www.pharmacypracticenews.com/Review-Articles/Medication-Safety/Article/11-24/IVWMS-Workarounds-Pharmacy-Safety/75413
https://www.pharmacypracticenews.com/Clinical/Article/11-24/Demystifying-Deprescribing-Provider-and-Patient-Buy-in-Is-Key/75393
https://www.pharmacypracticenews.com/Policy/Article/11-24/Drug-Compounding-Facilities-Extension/75395
https://www.pharmacypracticenews.com/Clinical/Article/11-24/Pharmacist-Managed-Remote-HF/75411
https://www.pharmacypracticenews.com/Online-First/Article/11-24/California-Confirms-First-Clade-I-Mpox-Case/75495
https://www.pharmacypracticenews.com/Policy/Article/11-24/NOPAIN-Act-to-Embrace-Seniors-in-Medicare-Part-D-Reimbursement-for-Nonopioid-Alternatives/75496
https://www.pharmacypracticenews.com/Clinical/Vaccination/Article/11-24/Pneumococcal-Conjugate-Vaccines-Recommendation/75402
https://www.pharmacypracticenews.com/Operations-and-Management/Endocrinology/Article/11-24/Machine-Learning-Obesity-Treatment-Prediction/75414
https://www.pharmacypracticenews.com/Operations-and-Management/Oncology/Article/11-24/STAQ-Pharma-Oncology-Collaboration/75412
https://www.pharmacypracticenews.com/Clinical/Inflammatory-Diseases/Article/11-24/RA-Pregnancy-Heart-Complications/75401
https://www.pharmacypracticenews.com/Industry-News/Oncology/Article/11-24/Drug-Labeling-for-Fludarabine-Phosphate-Updated-Under-FDAs-Project-Renewal/75510
https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/11-24/Short-Course-Antimicrobial-Therapy-Effectiveness/75394
https://www.pharmacypracticenews.com/Policy/Article/11-24/NASP-Urges-Action-on-Abysmal-Medicare-Part-D-Reimbursement/75408
https://www.pharmacypracticenews.com/Operations-and-Management/Inflammatory-Diseases/Article/11-24/SP-Pharmacist-Led-ED-Program-Boosts-Hepatitis-C-Treatment/75406
https://www.pharmacypracticenews.com/Operations-and-Management/Article/11-24/Specialty-Pharmacy-Success-Stories/75405
https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/11-24/Rapid-Molecular-Panel-ABx-Reduction/75399
https://www.pharmacypracticenews.com/Policy/Medication-Safety/Article/11-24/Counterfeit-Drug-Dangers-Online/75410
https://www.pharmacypracticenews.com/Operations-and-Management/Pulmonology/Article/11-24/Promise-and-Hurdles-In-Personalized-Medicine/75404
https://www.pharmacypracticenews.com/Operations-and-Management/Oncology/Article/11-24/Holistic-Oncology-Specialty-Pharmacists/75403
https://www.pharmacypracticenews.com/Online-First/Article/11-24/Benefits-of-Shingles-Vaccine-Outweigh-Risks-for-the-Immunocompromised/75518
https://www.pharmacypracticenews.com/Policy/Endocrinology/Article/11-24/A-War-Brewing-Over-GLP-1-Agonist-Production/75409
https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/11-24/Candida-Auris-Public-Health/75398
https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/11-24/CNS-Involvement-in-Immunocompromised-Shingles-Patients-Dont-Miss-the-Subtle-Signs/75519
https://www.pharmacypracticenews.com/Online-First/Article/11-24/RZV-Prevents-Shingles-in-Adults-With-Autoimmune-Diseases/75520
https://www.pharmacypracticenews.com/Online-First/Article/11-24/Second-Trump-Administration-Impact-on-340B-Program-to-Be-Determined/75523
https://www.pharmacypracticenews.com/Online-First/Article/11-24/Avian-Influenza-H5N1-California/75532
https://www.pharmacypracticenews.com/Online-First/Biosimilars/Article/11-24/Biosimilar-Formulary-Standardized-Approach/75543
https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/11-24/Biktarvys-Benefits-Extend-in-Older-Adults-With-HIV/75568
https://www.pharmacypracticenews.com/Online-First/Article/11-24/Beer-Drinkers-Lower-Quality-Diet-liver-disease-alcohol/75569
https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/11-24/Ziihera-Approval-HER2-Positive-Biliary-Tract-Cancer/75591
https://www.pharmacypracticenews.com/Online-First/Medication-Safety/Article/11-24/Baxter-Restarts-Some-IV-Solutions-Manufacturing-ISMP-Issues-Guidance-for-Imported-IV-Products/75330
https://www.pharmacypracticenews.com/Industry-News/Article/11-24/Enhancing-Patient-Safety-Through-Critical-Drug-Label-Improvements/75647
https://www.pharmacypracticenews.com/FDA-News/Hematology/Article/12-24/Revumenib-FDA-Approval-Leukemia-Treatment/75479
https://www.pharmacypracticenews.com/Clinical/Pain/Article/12-24/Ibuprofen-Injection-Shows-Better-Real-World-Outcomes-in-Comparative-Study/75497
https://www.pharmacypracticenews.com/Online-First/Article/12-24/A-Period-of-Uncertainty-Looms-for-GLP-1-Compounders/75506
https://www.pharmacypracticenews.com/Review-Articles/Medication-Safety/Article/12-24/Addressing-IVWMS-Workarounds/75469
https://www.pharmacypracticenews.com/Review-Articles/Biosimilars/Article/12-24/Pharmacists-Key-Role-in-The-Management-of-Humira-Biosimilars/75471
https://www.pharmacypracticenews.com/Review-Articles/Medication-Safety/Article/12-24/Medication-Errors-The-Year-in-Review/75473
https://www.pharmacypracticenews.com/Review-Articles/Medication-Safety/Article/12-24/How-to-Avoid-Groundhog-Day-Syndrome-When-Dealing-With-Hazardous-Drugs/75470
https://www.pharmacypracticenews.com/Review-Articles/Hematology/Article/12-24/Hemophilia-Gene-Therapy-Developments/75472
https://www.pharmacypracticenews.com/Online-First/Women’s-Health/Article/12-24/Contraceptive-Care-Access-Recommendations/75590
https://www.pharmacypracticenews.com/Online-First/Article/12-24/IRS-Guidance-Improves-Medication-Adherence/75621
https://www.pharmacypracticenews.com/Online-First/Medication-Safety/Article/12-24/Elderly-Polypharmacy-Deprescribing-Pharmacists/75624
https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/12-24/Bizengri-FDA-Approval/75656
https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/12-24/Imfinzi-Approval-Small-Cell-Lung-Cancer/75658
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Medication-Safety/Article/12-24/REMS-Compliance-Challenges-Solutions/75667
https://www.pharmacypracticenews.com/Online-First/Infectious-Diseases/Article/12-24/Syphilis-Epidemic-Treatment-Options-drug-shortages-STIs/75666
https://www.pharmacypracticenews.com/Operations-and-Management/Article/12-24/Manager-Strategies-For-Alleviating-Staff-Crisis-in-Compounding/75674
https://www.pharmacypracticenews.com/Online-First/Article/12-24/GLP-1s-Contribute-to-Lower-Risk-for-VTE-in-Patients-With-Diabetes/75684
https://www.pharmacypracticenews.com/Online-First/Article/12-24/Inconsistent-Progress-Toward-2030-Pharmacy-Goals-ASHP-Survey-Shows/75706
https://www.pharmacypracticenews.com/Online-First/Article/12-24/Building-the-Case-for-a-Centralized-Media-Fill-Program/75708
https://www.pharmacypracticenews.com/Online-First/Oncology/Article/12-24/Precision-Oncology-Effort-Blooms-in-North-Carolina/75710
https://www.pharmacypracticenews.com/Online-First/Infectious-Diseases/Article/12-24/Empiric-Antibiotic-Choices-for-Diabetic-Foot-Infections-Often-Discordant-With-Risk-Factors/75716
https://www.pharmacypracticenews.com/FDA-News/Article/12-24/Optimizing-Medication-Management-for-505-b-2-Drugs/75717
https://www.pharmacypracticenews.com/Operations-and-Management/Article/12-24/ISMP-Attending-to-Human-Factors-Would-Increase-Medication-Safety/75718
https://www.pharmacypracticenews.com/Online-First/Article/12-24/Blinatumomab-Increases-Disease-Free-Survival-for-Children-With-Leukemia/75719
https://www.pharmacypracticenews.com/Operations-and-Management/Pharmacogenomics/Article/12-24/Specialty-Pharmacy-Set-To-Meet-the-Challenges-Of-PGx-Clinical-Integration/75672
https://www.pharmacypracticenews.com/Operations-and-Management/Article/12-24/Act-Now-on-6-IV-Fluid-Conservation-Strategies/75677
https://www.pharmacypracticenews.com/Policy/Article/12-24/Troubleshooting-Steps-Needed-Now-For-2025-Supply-Chain-Enforcement/75673
https://www.pharmacypracticenews.com/Operations-and-Management/Medication-Safety/Article/12-24/DOAC-Prescribing-Support-Tool/75675
https://www.pharmacypracticenews.com/Clinical/Oncology/Article/12-24/Future-Bright-Oncology-Development/75678
https://www.pharmacypracticenews.com/Clinical/Article/12-24/Solid-Organ-Transplant-Maintenance-Immunossuppression/75679
https://www.pharmacypracticenews.com/Operations-and-Management/Article/12-24/AI-Pharmacy-Staffing-Solutions/75676
https://www.pharmacypracticenews.com/Online-First/Article/12-24/Healthcare-Worker-Burnout-Strategies/75750
https://www.pharmacypracticenews.com/Online-First/Article/12-24/Collaborative-Practice-Agreement-Reduces-Time-to-PrEP-Access/75754
https://www.pharmacypracticenews.com/Policy/Article/12-24/NSCLC-Therapeutics-Promising-Approvals-2024/75724
https://www.pharmacypracticenews.com/Policy/Endocrinology/Article/12-24/GLP-1-Agonists-FDA-Scrutiny-Dodge/75725
https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/12-24/FDA-Approved-Unloxcyt-Skin-Cancer/75760
https://www.pharmacypracticenews.com/Clinical/Hematology/Article/12-24/Gene-Therapy-Cost-Savings/75726
https://www.pharmacypracticenews.com/Operations-and-Management/Article/12-24/Specialty-Pharmacy-Market-Trends/75729
https://www.pharmacypracticenews.com/Industry-News/Article/12-24/Bluesight-Medication-Intelligence-Expansion/75768
https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/12-24/FDA-Approves-Ensacove-for-ALK-Positive-Locally-Advanced-or-Metastatic-NSCLC/75771
https://www.pharmacypracticenews.com/FDA-News/Hematology/Article/12-24/FDA-Approves-Ryoncil-for-SR-aGVHD/75778
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/12-24/Pharmacy-Technology-AI-Solutions/75779
https://www.pharmacypracticenews.com/Online-First/Article/12-24/NIOSH-Releases-Updated-List-of-Hazardous-Drugs-in-Healthcare-Settings/75789
https://www.pharmacypracticenews.com/Clinical/Hematology/Article/12-24/Harnessing-the-Potential-of-CAR-T-Cell-Therapy-for-Multiple-Myeloma/75734
https://www.pharmacypracticenews.com/Clinical/Hematology/Article/12-24/Effective-Corticosteroid-Treatment-cGVHD-Alternative/75735
https://www.pharmacypracticenews.com/Online-First/Article/12-24/FDA-Declares-End-to-Tirzepatide-Shortage/75792
https://www.pharmacypracticenews.com/Online-First/Article/12-24/Zepbound-Approved-for-Obstructive-Sleep-Apnea/75794
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/12-24/RFID-Future-Hospital-Pharmacy/75780
https://www.pharmacypracticenews.com/Industry-News/Article/12-24/FDA-Accepts-for-Priority-Review-Nuvation-Bios-NDA-for-Taletrectinib-to-Treat-Advanced-ROS1-positive-Non-Small-Cell-Lung-Cancer/75806
https://www.pharmacypracticenews.com/FDA-News/Article/12-24/FDA-Approves-Opdivo-Qvantig-for-Subcutaneous-Injection/75809
https://www.pharmacypracticenews.com/Online-First/Article/01-25/Just-Say-No-to-Paying-Cybersecurity-Ransoms/75832
https://www.pharmacypracticenews.com/Online-First/Article/01-25/IRA-Reduces-Specialty-Pharmacy-Reliance-on-Patient-Assistance-Programs/75833
https://www.pharmacypracticenews.com/Online-First/Article/01-25/Specialty-Pharmacists-Data-Mine-EHRs-To-Boost-Oncology-Drug-Adherence/75835
https://www.pharmacypracticenews.com/Online-First/Infectious-Diseases/Article/01-25/Flu-Increasing-Across-U-S/75846
https://www.pharmacypracticenews.com/Online-First/Article/01-25/Vaccination-for-Respiratory-Viruses-Lags/75847
https://www.pharmacypracticenews.com/Multimedia/Article/01-25/Malnutrition-Awareness-Week-Presenters-Discuss/75927
https://www.pharmacypracticenews.com/Clinical/Hematology/Article/01-25/CLL-SLL-Treatment-Landscape-Evolution/75918
https://www.pharmacypracticenews.com/Online-First/Article/01-25/Health-Systems-Specialty-Medications-Revenue/75929
https://www.pharmacypracticenews.com/Clinical/Nutrition/Article/01-25/Nutrition-Support-Patient-Survey/75919
https://www.pharmacypracticenews.com/Operations-and-Management/Article/01-25/Hospital-Pharmacy-Audit-Stressors/75915
https://www.pharmacypracticenews.com/Operations-and-Management/Article/01-25/Healthcare-Worker-Burnout-Prevention/75916
https://www.pharmacypracticenews.com/Operations-and-Management/Immunology/Article/01-25/Safe-Travel-Organ-Transplant/75917
https://www.pharmacypracticenews.com/Online-First/Article/01-25/Glucarpidase-Boosts-Recovery-From-Methotrexate-Induced-Acute-Kidney-Injury/75961
https://www.pharmacypracticenews.com/Online-First/Article/01-25/Breakthrough-in-EGFR-Mutated-NSCLC-Rybrevant-Plus-Lazcluze-Extends-Overall-Survival/75964
https://www.pharmacypracticenews.com/Operations-and-Management/Article/01-25/Pharmacist-Inpatient-Billing-Challenges/75920
https://www.pharmacypracticenews.com/FDA-News/GI-Disorders/Article/01-25/Tevimbra-Approved-for-Treatment-of-Gastric-and-Gastroesophageal-Junction-Cancers-in-Combination-With-Chemo/75967
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Medication-Safety/Article/01-25/Automated-Dispensing-Cabinets-Safety/75921
https://www.pharmacypracticenews.com/FDA-News/Article/01-25/FDA-Requires-GBS-Warning-for-RSV-Vaccines/75986
https://www.pharmacypracticenews.com/Clinical/Pain/Article/01-25/Despite-Risks-and-Scant-Evidence-Muscle-Relaxants-Still-Used-to-Treat-Chronic-Pain/75988
https://www.pharmacypracticenews.com/Policy/Oncology/Article/01-25/UNC-Pharmacy-Biomarker-Cancer-Treatments/75924
https://www.pharmacypracticenews.com/Online-First/Article/01-25/Avian-Flu-Control-Challenges/75987
https://www.pharmacypracticenews.com/Policy/Article/01-25/Reimbursement-Matters-Health-System/75922
https://www.pharmacypracticenews.com/Policy/Article/01-25/Trump-Administration-340B-Program/75923
https://www.pharmacypracticenews.com/Online-First/Article/01-25/Breast-Cancer-Population-Based-Genetic-Testing-Versus-Guideline-Based-Screening/75928
https://www.pharmacypracticenews.com/Online-First/Women’s-Health/Article/01-25/Environmental-Exposure-a-Risk-Factor-for-Breast-Cancer/75930
https://www.pharmacypracticenews.com/Online-First/Oncology/Article/01-25/Is-Breast-Cancer-Metastasis-a-Hereditary-Disorder/75932
https://www.pharmacypracticenews.com/Online-First/Oncology/Article/01-25/Rise-in-Breast-Cancer-Among-Young-Women-Requires-New-Models-of-Care/75931
https://www.pharmacypracticenews.com/Online-First/Article/01-25/CDC-Issues-Health-Alert-Subtype-Influenza-A-Among-Hospitalized-Patients/76003
https://www.pharmacypracticenews.com/Online-First/Article/01-25/FDA-Warns-Healthcare-Professionals-Not-to-Use-Epinephrine-Nasal-Solutions-From-BPI-Labs-and-Endo-USA/76013
https://www.pharmacypracticenews.com/FDA-News/Hematology/Article/01-25/FDA-Approves-Calquence-With-Bendamustine-and-Rituximab-for-Previously-Untreated-Mantle-Cell-Lymphoma/76021
https://www.pharmacypracticenews.com/FDA-News/GI-Disorders/Article/01-25/FDA-Approves-Lumakras-With-Vectibix-for-KRAS-G12C-Mutated-Colorectal-Cancer/76018
https://www.pharmacypracticenews.com/FDA-News/Medication-Safety/Article/01-25/FDA-Alert-Highlights-Smart-Pump-Software-Anomalies/76026
https://www.pharmacypracticenews.com/Policy/Article/01-25/Pharmacy-Comes-Full-Circle-as-Site-of-Care/76027
https://www.pharmacypracticenews.com/FDA-News/Women’s-Health/Article/01-25/Datopotamab-Deruxtecan-Dlnk-Approval-Breast-Cancer/76039
https://www.pharmacypracticenews.com/Online-First/Article/01-25/Public-Health-Experts-Criticize-WHO-Withdrawal/76042
https://www.pharmacypracticenews.com/Online-First/Infectious-Diseases/Article/01-25/Pharmacist-Led-HCV-Micro-Elimination-Program/76046
https://www.pharmacypracticenews.com/Online-First/Article/01-25/Health-System-Specialty-Pharmacies-Improve-Adherence/76056
https://www.pharmacypracticenews.com/Policy/Article/01-25/As-HHS-Secretary-Could-RFK-Jr-Actually-Damage-the-U-S-Vaccine-Program/76064
https://www.pharmacypracticenews.com/Industry-News/Article/01-25/Swisslog-Healthcare-Announces-Robotics-Partnership-With-BD/76082
https://www.pharmacypracticenews.com/Industry-News/Article/01-25/Camber-Pharmaceuticals-Introduces-Sirolimus-Oral-Solution/76098
https://www.pharmacypracticenews.com/Online-First/Article/01-25/ASHP-Pharmacy-Forecast-Hospital-Trends/76099
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/01-25/Telepharmacy-Advantages-Home-Health/76112
https://www.pharmacypracticenews.com/Policy/Article/01-25/Despite-Lawsuits-Books-and-Tweets-RFK-Jr-Still-Saying-He-Is-Not-an-Anti-Vaxxer/76115
https://www.pharmacypracticenews.com/FDA-News/Article/01-25/FDA-Approves-Novel-Nonopioid-Treatment-for-Moderate-to-Severe-Acute-Pain/76120
https://www.pharmacypracticenews.com/Online-First/Article/01-25/Government-Purge-of-CDCs-HIV-Web-Content-Alarms-ID-Pharmacists-and-Other-Experts/76125
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Medication-Safety/Article/01-25/Drug-Shortages-Data-Analytics/76152
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/02-25/RFID-Technology-Hospital-Pharmacies/76182
https://www.pharmacypracticenews.com/Industry-News/Article/02-25/Somerset-Launches-4-New-Ophthalmics-Products/76185
https://www.pharmacypracticenews.com/FDA-News/Medication-Safety/Article/02-25/FDA-Smartphone-Diabetes-Alerts/76191
https://www.pharmacypracticenews.com/Online-First/Pain/Article/02-25/Purdue-Pharma-New-Settlement/76194
https://www.pharmacypracticenews.com/Policy/Article/02-25/Reimbursement-of-Wasted-Drugs-CMS/76181
https://www.pharmacypracticenews.com/Policy/Article/02-25/Finance-Committee-Sends-RFK-Jr-Nomination-for-Full-Senate-Vote/76196
https://www.pharmacypracticenews.com/Clinical/Medication-Safety/Article/02-25/Joint-Commission-Medication-Safety-Changes/76172
https://www.pharmacypracticenews.com/Policy/Article/02-25/Hospital-Compliance-USP-Regulations-Care/76180
https://www.pharmacypracticenews.com/Policy/Article/02-25/NIOSH-Hazardous-Drugs-2024-List/76173
https://www.pharmacypracticenews.com/Clinical/Medication-Safety/Article/02-25/Horseshoe-Crab-Sustainability-Concern/76171
https://www.pharmacypracticenews.com/Policy/Women’s-Health/Article/02-25/Pharmacist-Abortion-Access-Washington/76179
https://www.pharmacypracticenews.com/Online-First/Article/02-25/Some-CDC-HIV-Web-Content-Gets-Restored-But-Gaps-Remain/76202
https://www.pharmacypracticenews.com/Clinical/Nutrition/Article/02-25/Parenteral-Nutrition-Shortage-Management/76178
https://www.pharmacypracticenews.com/Clinical/Cardiology/Article/02-25/Rheumatoid-Arthritis-Glucocorticoid-Treatment-Guidelines/76177
https://www.pharmacypracticenews.com/Clinical/Hematology/Article/02-25/Chronic-Lymphocytic-Leukemia-Treatment-Management/76176
https://www.pharmacypracticenews.com/Policy/Article/02-25/Specialty-Pharmacy-Healthcare-Trends/76175
https://www.pharmacypracticenews.com/Online-First/Article/02-25/Court-Grants-Temporary-Restraining-Orders-Against-NIH-Funding-Cuts/76208
https://www.pharmacypracticenews.com/FDA-News/Article/02-25/FDA-Approves-Emblaveo-to-Treat-Certain-Complicated-Intraabdominal-Infections/76210
https://www.pharmacypracticenews.com/Monographs-and-Whitepapers/Article/02-25/Decreasing-Postoperative-Adverse-Events-and-Waste-Costs-With-Low-Dose-Opioid-And-Ready-to-Administer-RTA-Medications/76214
https://www.pharmacypracticenews.com/Clinical/Medication-Safety/Article/02-25/Pharmacy-Board-Labeling-Regulations/76174
https://www.pharmacypracticenews.com/Online-First/Article/02-25/Judge-Orders-HHS-CDC-and-FDA-to-Restore-Deleted-Web-Pages/76227
https://www.pharmacypracticenews.com/Clinical/Oncology/Article/02-25/High-Rates-of-Polypharmacy-Among-Lung-Cancer-Patients-Even-Younger-Adults/76232
https://www.pharmacypracticenews.com/Online-First/Oncology/Article/02-25/Signals-From-Lungs-of-Cancer-Patients-May-Cause-Thrombosis/76233
https://www.pharmacypracticenews.com/Online-First/Oncology/Article/02-25/Managing-Respiratory-Distress-Symptoms-in-People-with-Lung-Cancer/76234
https://www.pharmacypracticenews.com/Online-First/Article/02-25/ASHP-Urges-Tariff-Exemptions-for-Medications-and-APIs-to-Prevent-Price-Increases-Drug-Shortages/76236
https://www.pharmacypracticenews.com/Online-First/Inflammatory-Diseases/Article/02-25/Basics-and-Benefits-of-Biosimilars-A-Rheumatologists-Take/76241
https://www.pharmacypracticenews.com/Online-First/Medication-Safety/Article/02-25/Compounding-Pharmacies-Inspections-GLP-1-Demand/76242
https://www.pharmacypracticenews.com/Policy/Article/02-25/Senate-Confirms-RFK-Jr-as-Health-Secretary/76245
https://www.pharmacypracticenews.com/FDA-News/Infectious-Diseases/Article/02-25/FDA-Approves-Penmenvy-GSKs-5-in-1-Meningococcal-Vaccine/76287
https://www.pharmacypracticenews.com/FDA-News/Infectious-Diseases/Article/02-25/FDA-Approves-First-Chikungunya-Vaccine-for-People-as-Young-as-12-Years-of-Age/76289
https://www.pharmacypracticenews.com/Industry-News/Article/02-25/Long-Grove-Pharmaceuticals-Joins-Growing-Call-for-Drug-Label-Improvements/76309
https://www.pharmacypracticenews.com/FDA-News/Article/02-25/Gomekli-Approved-for-Patients-With-Neurofibromatosis-Type-1/76301
https://www.pharmacypracticenews.com/FDA-News/Hematology/Article/02-25/Adcetris-Lymphoma-Treatment-Approval/76303
https://www.pharmacypracticenews.com/Industry-News/Article/02-25/Mesalamine-Launch-Amneal/76314
https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/02-25/FDA-Approves-Romvimza-Giant-Cell-Tumor/76305
https://www.pharmacypracticenews.com/Online-First/Hematology/Article/02-25/Darzalex-Delays-Multiple-Myeloma-Transition/76307
https://www.pharmacypracticenews.com/Online-First/Article/02-25/ACIP-Meeting-Postponed/76317
https://www.pharmacypracticenews.com/Online-First/Article/02-25/Primary-Immunodeficiency-Treatment-and-Support/76324
https://www.pharmacypracticenews.com/Online-First/Article/02-25/Sepsis-Tips-for-Early-Identification-and-Home-Based-Prevention/76325
https://www.pharmacypracticenews.com/Online-First/Article/02-25/FDA-Declares-End-to-Semaglutide-Shortage-Clock-Ticking-on-Compounded-Versions/76337
https://www.pharmacypracticenews.com/FDA-News/Article/02-25/Chenodiol-FDA-Approval-CTX-Treatment/76335
https://www.pharmacypracticenews.com/Online-First/Article/02-25/Theres-Really-No-Debate-Lightly-Sedate-Whenever-Possible/76341
https://www.pharmacypracticenews.com/Online-First/Article/02-25/Effective-Sepsis-Treatments-Continue-to-Evolve/76344
https://www.pharmacypracticenews.com/Online-First/Article/02-25/Calcium-Often-Not-Helpful-After-Cardiac-Arrest/76346
https://www.pharmacypracticenews.com/Online-First/Article/02-25/Pharmacy-Staff-Burnout-Solutions/76348
https://www.pharmacypracticenews.com/Online-First/Article/02-25/Is-It-Safe-to-De-escalate-Antibiotics-in-Sepsis-Patients/76345
https://www.pharmacypracticenews.com/Online-First/Article/02-25/First-U-S-Measles-Death-in-10-Years-Reported-in-Texas-Outbreak/76355
https://www.pharmacypracticenews.com/Policy/Article/02-25/FDA-Vaccine-Advisory-Committee-Meeting-Canceled/76394
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Critical-Care/Article/02-25/Telecritical-Care-Pharmacist-Role/76398
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Medication-Safety/Article/02-25/GLP-1-Agonists-SGLT2-Inhibitors-Preoperative-Withholding/76402
https://www.pharmacypracticenews.com/FDA-News/GI-Disorders/Article/02-25/Tevimbra-FDA-Approval-ESCC/76409
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Critical-Care/Article/02-25/AI-Critical-Care-Pharmacy/76422
https://www.pharmacypracticenews.com/Online-First/Article/02-25/New-Legal-Weapons-Against-GLP-1-Compounders-Emerge/76433
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Medication-Safety/Article/02-25/Top-Hazards-for-Pharmacy-Tech/76431
https://www.pharmacypracticenews.com/Policy/Article/03-25/Measles-Vaccination-Importance-Advocacy/76435
https://www.pharmacypracticenews.com/FDA-News/Article/03-25/FDA-Clears-Second-QIAstat-Dx-Mini-GI-Rapid-Diagnostic-Test/76447
https://www.pharmacypracticenews.com/Covid-19/Article/03-25/Pemivibart-Monoclonal-Antibody-COVID/76449
https://www.pharmacypracticenews.com/Online-First/Article/03-25/Measles-Death-New-Mexico/76450
https://www.pharmacypracticenews.com/FDA-News/Article/03-25/FDA-Approves-First-Interchangeable-Omalizumab-Biosimilar/76452
https://www.pharmacypracticenews.com/Review-Articles/Article/03-25/Parenteral-Nutrition-Therapy/76465
https://www.pharmacypracticenews.com/Clinical/Oncology/Article/03-25/A-Good-Year-for-CAR-T-Therapies/76467
https://www.pharmacypracticenews.com/Clinical/Oncology/Article/03-25/Breast-Cancer-Treatment-Advances/76468
https://www.pharmacypracticenews.com/Covid-19/Article/03-25/Ensitrelvir-Reduced-the-Risk-for-COVID-19-by-67/76498
https://www.pharmacypracticenews.com/Online-First/Article/03-25/Tecovirimat-Clinical-Trial-Results/76499
https://www.pharmacypracticenews.com/Online-First/Article/03-25/Mpox-Outbreak-Uganda-varicella-zoster-CROI-2025/76500
https://www.pharmacypracticenews.com/Clinical/Critical-Care/Article/03-25/2024-s-Emergency-Medicine-Pearls/76475
https://www.pharmacypracticenews.com/Operations-and-Management/Article/03-25/503B-Vendor-Evaluation-Crucial/76480
https://www.pharmacypracticenews.com/Policy/Endocrinology/Article/03-25/Compounding-Pharmacies-GLP-1-Compliance-Challenges/76486
https://www.pharmacypracticenews.com/Policy/Article/03-25/Weldons-Nomination-to-Head-CDC-Withdrawn/76511
https://www.pharmacypracticenews.com/Clinical/Oncology/Article/03-25/Breast-Cancer-Disparities-and-Black-Women/76471
https://www.pharmacypracticenews.com/Operations-and-Management/Inflammatory-Diseases/Article/03-25/Adalimumab-Biosimilar-Differentiation/76485
https://www.pharmacypracticenews.com/Clinical/Oncology/Article/03-25/Voraxaze-Improves-Methotrexate-Nephrotoxicity-Recovery/76469
https://www.pharmacypracticenews.com/FDA-News/Article/03-25/FDA-Approves-Label-Changes-for-Buprenorphine-ER-Injection/76514
https://www.pharmacypracticenews.com/Clinical/Oncology/Article/03-25/Rybrevant-Lazcluze-Lung-Cancer/76472
https://www.pharmacypracticenews.com/Clinical/Oncology/Article/03-25/Integrative-Oncology-Modalities-Importance/76473
https://www.pharmacypracticenews.com/Operations-and-Management/Article/03-25/Ethical-Drug-Shortages-Dilemma/76466
https://www.pharmacypracticenews.com/Operations-and-Management/Article/03-25/Specialty-Pharmacies-Reducing-Medication-Nonadherence/76483
https://www.pharmacypracticenews.com/Operations-and-Management/Article/03-25/A-Professional-Tidal-Wave-of-Opportunities-and-Challenges/76484
https://www.pharmacypracticenews.com/Operations-and-Management/Medication-Safety/Article/03-25/Medication-Errors-Dose-Quantity-Safety/76481
https://www.pharmacypracticenews.com/Clinical/Women’s-Health/Article/03-25/Young-Women-Breast-Cancer-Empowerment/76470
https://www.pharmacypracticenews.com/Operations-and-Management/Article/03-25/Hospital-Pharmacy-Transitions-Challenges/76478
https://www.pharmacypracticenews.com/Operations-and-Management/Article/03-25/Take-a-Closer-Look-at-340B-Spend-Data/76482
https://www.pharmacypracticenews.com/Operations-and-Management/Medication-Safety/Article/03-25/Excellence-Medication-Safety-Certification/76479
https://www.pharmacypracticenews.com/Online-First/Article/03-25/Higher-Case-Counts-More-Serious-Illness-in-Puerto-Rico-Dengue-Outbreak-CDC-Issues-Alert/76547
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/03-25/DEA-Warns-of-EHR-Hacking-Fraud/76477
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/03-25/Just-Say-No-to-Paying-Cybersecurity-Ransom/76476
https://www.pharmacypracticenews.com/FDA-News/Article/03-25/Keytruda-Receives-Traditional-Approval-for-Some-Patients-With-HER2-Positive-Gastric-or-GEJ-Adenocarcinoma/76564
https://www.pharmacypracticenews.com/Clinical/Oncology/Article/03-25/Polypharmacy-Cancer-Adults-Prevalence/76474
https://www.pharmacypracticenews.com/Policy/Article/03-25/Every-1-in-NIH-Research-Funding-Returns-2-56-to-the-U-S-Economy/76585
https://www.pharmacypracticenews.com/Industry-News/Article/03-25/Meitheal-Pharmaceuticals-Launches-Alprostadil-Injection-USP-in-Vial-Form/76594
https://www.pharmacypracticenews.com/Online-First/Nutrition/Article/03-25/Pharmacist-Advancements-Parenteral-Nutrition/76596
https://www.pharmacypracticenews.com/Online-First/Nutrition/Article/03-25/Malnutrition-Monitoring-Ambulatory-Cancer-Clinics/76601
https://www.pharmacypracticenews.com/Multimedia/Infectious-Diseases/Article/03-25/HIV-Drugs-Weight-Gain-CROI-2025/76604
https://www.pharmacypracticenews.com/Online-First/Article/03-25/Plan-Ahead-for-Ongoing-PN-Component-Shortages/76607
https://www.pharmacypracticenews.com/FDA-News/Article/03-25/FDA-Grants-Third-Indication-to-Fabhalta-for-C3G/76609
https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/03-25/Cabometyx-Approval-Pancreatic-Neuroendocrine-Tumor/76614
https://www.pharmacypracticenews.com/FDA-News/Article/03-25/FDA-Approves-Egrifta-WR-to-Treat-Excess-Visceral-Abdominal-Fat-in-Adults-With-HIV/76626
https://www.pharmacypracticenews.com/FDA-News/Article/03-25/FDA-Approves-First-in-Class-Blujepa-to-Treat-uUTIs-in-Females-12-and-Older/76627
https://www.pharmacypracticenews.com/Online-First/Article/03-25/Tips-for-Avoiding-Medication-Related-Feeding-Tube-Clogs-Discussed-at-ASPEN-Conference/76595
https://www.pharmacypracticenews.com/Clinical/Oncology/Article/03-25/Survivorship-Planning-for-Melanoma-Patients/76562
https://www.pharmacypracticenews.com/Online-First/Article/04-25/Bavarian-Nordic-Launches-Chikungunya-Vaccine/76535
https://www.pharmacypracticenews.com/FDA-News/Article/04-25/FDA-Recommends-Influenza-Vaccine-Composition-for-the-2025-2026-U-S-Influenza-Season/76538
https://www.pharmacypracticenews.com/Monographs-and-Whitepapers/Article/04-25/Pediatric-Parenteral-lipid-injectable-emulsions/76551
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Critical-Care/Article/04-25/AI-Medication-Cluster-Prediction/76559
https://www.pharmacypracticenews.com/Clinical/Article/04-25/Pharmacists-Play-Important-Role-in-Sun-Safety-Education/76577
https://www.pharmacypracticenews.com/Monographs-and-Whitepapers/Article/04-25/antimicrobials-antibiotics/76590
https://www.pharmacypracticenews.com/Multimedia/Infectious-Diseases/Article/04-25/Cabotegravir-Rilpivirine-HIV-Treatment-CROI-2025/76597
https://www.pharmacypracticenews.com/Review-Articles/Medication-Safety/Article/04-25/Hazardous-Drug-Residue-Monitoring/76515
https://www.pharmacypracticenews.com/Review-Articles/Medication-Safety/Article/04-25/Responding-to-NIOSH-Hazardous-Drugs-Update/76516
https://www.pharmacypracticenews.com/Operations-and-Management/Medication-Safety/Article/04-25/10-Compounding-Safety-Strategies/76523
https://www.pharmacypracticenews.com/Multimedia/Infectious-Diseases/Article/04-25/HIV-HBV-Coinfection-Bictegravir-CROI-2025/76602
https://www.pharmacypracticenews.com/Operations-and-Management/Article/04-25/Cleanroom-HVAC-Engineering-Concepts/76522
https://www.pharmacypracticenews.com/Operations-and-Management/Article/04-25/Sterile-Compounding-Designated-Person/76517
https://www.pharmacypracticenews.com/Operations-and-Management/Article/04-25/Centralized-Media-Fill-Program-Benefits/76521
https://www.pharmacypracticenews.com/Operations-and-Management/Article/04-25/IV-Waste-Reduction-Strategies/76520
https://www.pharmacypracticenews.com/Operations-and-Management/Article/04-25/Emotional-Intelligence-Sterile-Compounding-Training/76518
https://www.pharmacypracticenews.com/Operations-and-Management/Article/04-25/Category-3-Compounding-Safety-Standards/76519
https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/04-25/Imfinzi-Bladder-Cancer/76732
https://www.pharmacypracticenews.com/Monographs-and-Whitepapers/Article/04-25/sulbactam-durlobactam-crab-antimicrobials-antimicrobial-resistance/76702
https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/04-25/Pluvicto-Expansion-Prostate-Cancer/76727
https://www.pharmacypracticenews.com/Industry-News/Article/04-25/Meitheal-Pharmaceuticals-Announces-Approval-and-Launch-of-Liraglutide-Injection/76735
https://www.pharmacypracticenews.com/Industry-News/Article/04-25/Amneal-Boruzu-Subcutaneous-Formulation-Launch/76739
https://www.pharmacypracticenews.com/Online-First/Medication-Safety/Article/04-25/Gene-Therapy-Occupational-Safety/76734
https://www.pharmacypracticenews.com/Policy/Article/04-25/ID-and-Public-Health-Experts-You-Just-Cant-Replace-Federal-Expertise/76742
https://www.pharmacypracticenews.com/FDA-News/Hematology/Article/04-25/Qfitlia-FDA-Approval-Hemophilia-Treatment/76745
https://www.pharmacypracticenews.com/Online-First/Article/04-25/NIH-Funding-Cuts-Impact/76758
https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/04-25/Opdivo-with-Yervoy-Colorectal-Cancer-Approval/76802
https://www.pharmacypracticenews.com/Clinical/Oncology/Article/04-25/Adjuvant-Nivolumab-Bladder-Cancer-Effective/76658
https://www.pharmacypracticenews.com/Clinical/Pain/Article/04-25/Overcoming-Pain-Care-Stigma/76654
https://www.pharmacypracticenews.com/Online-First/Article/04-25/Tariffs-Pharmaceutical-Impacts/76825
https://www.pharmacypracticenews.com/Clinical/Critical-Care/Article/04-25/When-Illicit-Drugs-Crash-the-Party-ED-Pharmacists-Have-the-Antidotes/76655
https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/04-25/Opdivo-With-Yervoy-HCC-Treatment-Approval/76832
https://www.pharmacypracticenews.com/Covid-19/Article/04-25/Oral-Ensitrelvir-Protects-Against-COVID/76837
https://www.pharmacypracticenews.com/Online-First/Article/04-25/IL-6-Promising-Biomarker-for-Diagnosing-Sepsis-Early/76838
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/04-25/Insulin-Infusion-Calculators-Cleveland-Clinic/76840
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/04-25/ASHP-ShiftRx-Pharmacy-Staffing/76845
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Critical-Care/Article/04-25/Telecritical-Care-Building-Rapport/76667
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Critical-Care/Article/04-25/AI-Predicts-Fluid-Overload/76666
https://www.pharmacypracticenews.com/Operations-and-Management/Article/04-25/IV-Waste-Reduction-Strategies/76665
https://www.pharmacypracticenews.com/Online-First/Article/04-25/Better-Clinical-Outcomes-Seen-With-Fetroja-as-Empiric-Not-Salvage-Therapy/76859
https://www.pharmacypracticenews.com/Online-First/Article/04-25/ACIP-Recommends-GSKs-5-in-1-Meningococcal-Vaccine/76863
https://www.pharmacypracticenews.com/Online-First/Article/04-25/ACIP-Recommends-Expanded-Use-for-RSV-Vaccines/76864
https://www.pharmacypracticenews.com/Clinical/Article/04-25/Promoting-Professional-Identity-Combats-Burnout/76662
https://www.pharmacypracticenews.com/Policy/Article/04-25/Reimbursement-Matters-Health-System/76664
https://www.pharmacypracticenews.com/Review-Articles/Article/04-25/Medication-Errors-Year-in-Review/76883
https://www.pharmacypracticenews.com/Policy/Article/04-25/GLP-1-Lilly-FDA-Lawsuit/76663
https://www.pharmacypracticenews.com/Clinical/Critical-Care/Article/04-25/ICU-Sedation-Protocols-Expert-Panel/76660
https://www.pharmacypracticenews.com/Clinical/Critical-Care/Article/04-25/Stress-Ulcer-Prophylaxis-Guidelines-Recommendations/76659
https://www.pharmacypracticenews.com/Clinical/Medication-Safety/Article/04-25/Anticoagulation-End-of-Life-Management-Considerations/76657
https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/04-25/Ensitrelvir-COVID-19-Prevention-Efficacy/76656
https://www.pharmacypracticenews.com/Online-First/Article/04-25/Lumicera-Health-Services-Partners-With-Costco-Pharmacy-for-Cost-Plus-SP-Services/76921
https://www.pharmacypracticenews.com/Online-First/Biosimilars/Article/04-25/Trump-Executive-Order-Drug-Prices/76924
https://www.pharmacypracticenews.com/FDA-News/Article/04-25/Vanrafia-Accelerated-FDA-Approval-IgA-Nephropathy/76926
https://www.pharmacypracticenews.com/Clinical/Oncology/Article/04-25/Melanoma-Survivor-Sun-Protection/76661
https://www.pharmacypracticenews.com/Online-First/Article/04-25/CDC-Chikungunya-Vaccine-Adoption/76937
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Oncology/Article/04-25/Teledermoscopy-Melanoma-Diagnosis-Technology/76927
https://www.pharmacypracticenews.com/Clinical/Medication-Safety/Article/04-25/Medication-Safety-Best-Practices/76928
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/04-25/Lessons-Learned-from-2-RFID-Veterans/76954
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/04-25/6-Steps-That-Could-Spur-Higher-RFID-Implementation/76955
https://www.pharmacypracticenews.com/Clinical/Medication-Safety/Article/04-25/GLP-1-Receptor-Agonists-Surgery-Guidelines/76929
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/04-25/7-Strategies-for-RFID-Success/76956
https://www.pharmacypracticenews.com/Clinical/Inflammatory-Diseases/Article/04-25/Infliximab-Maintenance-Therapy-Immunosuppressant/76963
https://www.pharmacypracticenews.com/Clinical/Article/04-25/IG-Therapy-SARS-CoV-2-Antibody-Protection/76931
https://www.pharmacypracticenews.com/Policy/Article/04-25/Please-Dont-Stumble-on-These-4-Payment-Basics/76966
https://www.pharmacypracticenews.com/Clinical/Pain/Article/04-25/Astronauts-Chronic-Back-Pain/76961
https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/04-25/HIV-Epidemic-Pharmacists-PrEP-Expansion/76932
https://www.pharmacypracticenews.com/Online-First/Article/04-25/Tariffs-Market-Growth-on-Tap-at-Doug-Longs-AXS25-Summit-Swan-Song/76988
https://www.pharmacypracticenews.com/Clinical/Pain/Article/04-25/Cryoablation-Abdominal-Surgery-Pain-Relief/76962
https://www.pharmacypracticenews.com/Online-First/Article/04-25/IDNs-Will-Use-AI-Other-Tools-to-Improve-Cell-and-Gene-Therapy/76994
https://www.pharmacypracticenews.com/Monographs-and-Whitepapers/Article/04-25/RFID-radio-frequency-identification-children-s-hospitals/76995
https://www.pharmacypracticenews.com/Online-First/Oncology/Article/04-25/AXS25-Panel-Medically-Integrated-Dispensing-Is-Best-for-Oncology-Patients/77000
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/04-25/Healthcare-AI-Safety-Concerns/77005
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/04-25/Pharmaceutical-Compounding-Environmental-Sampling/77003
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/04-25/Healthcare-Data-Breach-Increase/77004
https://www.pharmacypracticenews.com/FDA-News/Article/05-25/-First-and-Only-Ready-to-Dilute-Multi-Dose-Vial-of-Thiotepa-Approved/77067
https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/05-25/Penpulimab-kcqx-Nasopharyngeal-Carcinoma-Treatment/77073
https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/05-25/Avutometinib-Defactinib-Combination-LGSOC-Treatment/77076
https://www.pharmacypracticenews.com/Operations-and-Management/Article/05-25/Sustainable-Healthcare-Diagnostic-Testing/77040
https://www.pharmacypracticenews.com/Policy/Medication-Safety/Article/05-25/Trump-Tariffs-Pharmaceutical-Impact/77025
https://www.pharmacypracticenews.com/Clinical/Nutrition/Article/05-25/Pharmacist-Guidelines-Parenteral-Nutrition/77024
https://www.pharmacypracticenews.com/Online-First/Medication-Safety/Article/05-25/ASHP-Drug-Shortage-Report/77109
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/05-25/Pharmacy-Cybersecurity-Priorities/77107
https://www.pharmacypracticenews.com/Online-First/Pain/Article/05-25/NFL-Opioid-Prescription-Monitoring-Program/77117
https://www.pharmacypracticenews.com/Online-First/Article/05-25/Neuro-Ocular-and-Otic-Syphilis-Cases-Increase/77125
https://www.pharmacypracticenews.com/Online-First/Article/05-25/Targeted-Drug-Delivery-Scores-High-on-Patient-Satisfaction/77126
https://www.pharmacypracticenews.com/Policy/Article/05-25/AE-Reports-Prompt-FDA-CDC-to-Hit-Pause-on-Ixchiq-Vaccine/77129
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Critical-Care/Article/05-25/Insulin-Infusion-Calculators/77044
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/05-25/Telemedicine-Substance-Use-Disorder/77043
https://www.pharmacypracticenews.com/Operations-and-Management/Article/05-25/Pharmacist-Burnout-Reduction-Strategies/77041
https://www.pharmacypracticenews.com/Policy/Article/05-25/USPSTF-Updated-Guidance-for-Syphilis-Screening-During-Pregnancy/77137
https://www.pharmacypracticenews.com/Online-First/Article/05-25/CDC-Accepts-ACIP-Vaccine-Recommendations-for-Chikungunya-Vaccine-Only/77142
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Oncology/Article/05-25/Automated-Cancer-Patient-Follow-Up/77042
https://www.pharmacypracticenews.com/FDA-News/Article/05-25/FDA-Approves-BLA-for-Novavaxs-COVID-19-Vaccine/77150
https://www.pharmacypracticenews.com/Policy/Article/05-25/Cooperation-503A-503B-Compounders-Regulatory-Challenges/77039
https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/05-25/FDA-Approves-Zynyz-for-Squamous-Cell-Carcinoma-of-the-Anal-Canal/77160
https://www.pharmacypracticenews.com/FDA-News/Article/05-25/FDA-Approves-Welireg-PPGL-Treatment/77165
https://www.pharmacypracticenews.com/Policy/Article/05-25/New-FDA-COVID-Vaccine-Recs/77171
https://www.pharmacypracticenews.com/Clinical/Oncology/Article/05-25/Oncology-Pharmacists-Deemed-a-Valuable-Addition-to-Cancer-Care-Team/77026
https://www.pharmacypracticenews.com/FDA-News/Article/05-25/VRBPAC-Recommends-New-SARS-CoV-2-Strain-for-Updated-COVID-19-Vaccines/77196
https://www.pharmacypracticenews.com/Policy/Article/05-25/Sterile-Compounding-Safety-Importance/77038
https://www.pharmacypracticenews.com/Policy/Article/05-25/Lets-Not-Forget-About-Revenue-Generating-Processes/77037
https://www.pharmacypracticenews.com/Clinical/Medication-Safety/Article/05-25/Pharmacist-Gene-Therapy-Safety-Guidelines/77036
https://www.pharmacypracticenews.com/Clinical/Immunology/Article/05-25/Immunoglobulin-Therapy-Aseptic-Meningitis-Syndrome/77035
https://www.pharmacypracticenews.com/Clinical/Oncology/Article/05-25/Early-Real-World-Data-Positive-for-NMIBC-Immunotherapy/77033
https://www.pharmacypracticenews.com/Clinical/Biosimilars/Article/05-25/Biosimilars-Patient-Access-Healthcare-Costs/77034
https://www.pharmacypracticenews.com/Clinical/Critical-Care/Article/05-25/In-ICU-Early-Mobilization-Key-To-Achieving-Best-Outcomes/77032
https://www.pharmacypracticenews.com/Clinical/Nutrition/Article/05-25/Preventing-Feeding-Tube-Occlusions-Strategies/77031
https://www.pharmacypracticenews.com/Online-First/Article/05-25/Insurance-Restrictions-Low-Reimbursement-Hitting-Pharmacies-on-GLP-1s/77212
https://www.pharmacypracticenews.com/Online-First/Article/05-25/Trump-Executive-Orders-Pharmaceuticals/77219
https://www.pharmacypracticenews.com/Clinical/Nutrition/Article/05-25/Enteral-Nutrition-Hemodynamically-Unstable-Patients/77030
https://www.pharmacypracticenews.com/Clinical/Nutrition/Article/05-25/Parenteral-Nutrition-Order-Review/77028
https://www.pharmacypracticenews.com/Online-First/Article/05-25/Nonoccupational-HIV-Post-Exposure-Prevention/77230
https://www.pharmacypracticenews.com/Multimedia/Article/05-25/Tariffs-Expected-to-Worsen-Shortages-Increase-Drug-Prices-and-Hurt-Healthcare/77240
https://www.pharmacypracticenews.com/Clinical/Nutrition/Article/05-25/Malnutrition-Tests-Outpatient-Oncology/77029
https://www.pharmacypracticenews.com/Clinical/Nutrition/Article/05-25/Cancer-Cachexia-Treatment-Challenges/77027
https://www.pharmacypracticenews.com/Industry-News/Article/05-25/Meitheal-Pharmaceuticals-Launches-Generic-Paclitaxel/77247
https://www.pharmacypracticenews.com/Industry-News/Article/05-25/A-forall-Announces-First-U-S-Launch-of-Tromethamine-Injection-18-g-500-mL/77248
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/06-25/AI-Benefits-Rural-Hospitals/77057
https://www.pharmacypracticenews.com/Online-First/Article/06-25/Olanzapine-Found-Effective-for-Managing-TKI-Related-Side-Effects/77167
https://www.pharmacypracticenews.com/Covid-19/Article/06-25/COVID-Vaccine-Removed-CDC-Recommendations-Kids-Pregnancy/77221
https://www.pharmacypracticenews.com/Online-First/Article/06-25/Beyond-Pass-and-No-Pass-Making-Sampling-Data-Work-for-You/77227
https://www.pharmacypracticenews.com/Industry-News/Article/06-25/Amneal-Launches-GLP-1-Agonist-Exenatide-Injection/77244
https://www.pharmacypracticenews.com/Opinion/Article/06-25/So-You-Are-Being-Sued/77237
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/06-25/Pharmacy-Robotic-Automated-Systems/77056
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/06-25/Is-IVWMS-Adoption-Rate-Fast-Enough/77052
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/06-25/Progress-Toward-the-Autonomous-Pharmacy-Hows-It-Going/77050
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/06-25/AI-Tools-and-Vendors-Choose-Wisely/77051
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/06-25/Allegheny-General-Hospitals-ADC-Journey/77053
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/06-25/Rx-Shortage-Dashboard-Drives-Medal-Winning-Plan/77054
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/06-25/Evolving-340B-Program-Requires-Nimble-Administrators/77055
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/06-25/RDT-BSI-Biofire-Time-to-Therapy/77293
https://www.pharmacypracticenews.com/Online-First/Article/06-25/Obesity-Impact-Beta-Lactam-Antibiotics-Treatment/77294
https://www.pharmacypracticenews.com/Online-First/Article/06-25/Recurrent-CDI-Strategies/77295
https://www.pharmacypracticenews.com/Covid-19/Infectious-Diseases/Article/06-25/Moderna-COVID-19-Vaccine-Approval/77326
https://www.pharmacypracticenews.com/Multimedia/Infectious-Diseases/Article/06-25/antibiotics-pipeline-sulopenem-tebipenem-cefepime-enmetazobactam/77327
https://www.pharmacypracticenews.com/Opinion/Immunology/Article/06-25/Pharmacists-Spring-Allergy-Management-Tips/77332
https://www.pharmacypracticenews.com/Online-First/Infectious-Diseases/Article/06-25/MAHA-Report-on-Childrens-Health-Distorts-Evidence-Experts-Say/77341
https://www.pharmacypracticenews.com/Online-First/Immunology/Article/06-25/FMT-Enhances-Immunotherapy-Effectiveness/77347
https://www.pharmacypracticenews.com/Online-First/Infectious-Diseases/Article/06-25/Moderna-Avian-Influenza-Vaccine/77346
https://www.pharmacypracticenews.com/Online-First/Infectious-Diseases/Article/06-25/Hepatitis-C-Treatment-Funding-Senate-Bill-Cassidy-Chris-Van-Hollen/77348
https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/06-25/-FDA-Approves-Nubeqa-for-Metastatic-Castration-Sensitive-Prostate-Cancer/77357
https://www.pharmacypracticenews.com/Industry-News/Article/06-25/Sanofi-Beyfortus-Shipping-RSV/77362
https://www.pharmacypracticenews.com/Online-First/Medication-Safety/Article/06-25/Medication-Safety-Good-Catches-Improvement/77356
https://www.pharmacypracticenews.com/Online-First/Article/06-25/Workflow-Assessment-Makes-the-Most-of-Sterile-Compounding-Robot-Productivity/77359
https://www.pharmacypracticenews.com/Online-First/Article/06-25/Why-Are-Fewer-Pharmacy-Residents-Completing-Their-Training/77364
https://www.pharmacypracticenews.com/Online-First/Article/06-25/Hot-340B-Topics-From-Winter-Coalition-Conference/77365
https://www.pharmacypracticenews.com/Online-First/Infectious-Diseases/Article/06-25/FDA-Approves-Clesrovimab-Respiratory-Syncytial-Virus/77387
https://www.pharmacypracticenews.com/Policy/Article/06-25/Purge-of-ACIP-by-R-F-K-Jr-Condemned-by-PharmDs-MDs-and-Others/77389
https://www.pharmacypracticenews.com/Online-First/Article/06-25/Humira-Biosimilar-Clinical-Success/77402
https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/06-25/FDA-Approves-Ibtrozi-for-ROS1-Positive-NSCLC/77407
https://www.pharmacypracticenews.com/Online-First/Article/06-25/Pharmacist-Managed-Diabetes-Program-Significantly-Cuts-A1c-Levels/77409
https://www.pharmacypracticenews.com/Online-First/Article/06-25/Pharmacists-Show-Their-Worth-in-Pediatric-Penicillin-Allergy-Delabeling/77410
https://www.pharmacypracticenews.com/FDA-News/Article/06-25/FDA-Approves-Expanded-Indication-for-Mavyret-for-Acute-HCV/77413
https://www.pharmacypracticenews.com/Online-First/Oncology/Article/06-25/Imfinzi-Immunotherapy-Gastric-Cancer/77433
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/06-25/AI-Prescribing-Medications-Legislation/77324
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/06-25/Many-Ways-to-Guard-Against-Cyberattacks/77323
https://www.pharmacypracticenews.com/Clinical/Critical-Care/Article/06-25/ICU-Altered-Mental-Status/77322
https://www.pharmacypracticenews.com/Clinical/Oncology/Article/06-25/ADCs-Gynecologic-Malignancies-Management-Toxicities/77321
https://www.pharmacypracticenews.com/Operations-and-Management/Article/06-25/Pharmacist-Burnout-Prevention-Strategies/77314
https://www.pharmacypracticenews.com/Clinical/Oncology/Article/06-25/Gel-Reduces-Anti-EGFR-Rash/77320
https://www.pharmacypracticenews.com/Clinical/Oncology/Article/06-25/Integrative-Oncology-Herbal-Supplements/77313
https://www.pharmacypracticenews.com/Policy/Article/06-25/Managing-In-House-Pharmacy-340B-Program/77316
https://www.pharmacypracticenews.com/Policy/Article/06-25/Without-Normal-Vetting-R-F-K-Jr-Appoints-New-Folks-to-ACIP/77451
https://www.pharmacypracticenews.com/Clinical/Medication-Safety/Article/06-25/Medication-Error-Rates-Benchmarking/77319
https://www.pharmacypracticenews.com/Online-First/Oncology/Article/06-25/T-DXd-Pertuzumab-Breast-Cancer/77455
https://www.pharmacypracticenews.com/Clinical/Immunology/Article/06-25/Immunologic-and-Anaphylactoid-Reactions-in-Ig-Therapy/77318
https://www.pharmacypracticenews.com/Clinical/Pain/Article/06-25/Suzetrigine-Nonopioid-Acute-Pain/77317
https://www.pharmacypracticenews.com/FDA-News/Article/06-25/Pembrolizumab-Approval-Head-Neck-Carcinoma/77450
https://www.pharmacypracticenews.com/Clinical/Nutrition/Article/06-25/Supporting-Nutrition-Patients-Throughout-Their-Treatment-Path/77315
https://www.pharmacypracticenews.com/FDA-News/Article/06-25/Zusduri-Approved-for-Recurrent-Low-Grade-Intermediate-Risk-Non-Muscle-Invasive-Bladder-Cancer/77449
https://www.pharmacypracticenews.com/Clinical/Oncology/Article/06-25/New-Treatment-Strategy-Proposed-for-Some-Patients-With-HR-Positive-HER2-Negative-Advanced-Breast-Cancer/77467
https://www.pharmacypracticenews.com/Clinical/Oncology/Article/06-25/Novel-Therapy-Found-Effective-for-Polycythemia-Vera-in-Phase-3-Trial/77468
https://www.pharmacypracticenews.com/Clinical/Oncology/Article/06-25/Structured-Exercise-Improves-Survival-in-Stage-II-III-Colon-Cancer/77469
https://www.pharmacypracticenews.com/Policy/Article/06-25/DSCSA-Exception-Handling-Importance/77471
https://www.pharmacypracticenews.com/Clinical/Article/06-25/Chronic-Graft-Versus-Host-Disease-Management/77436
https://www.pharmacypracticenews.com/Industry-News/Article/06-25/Prefilled-Ketamine-Syringes-Coming-Soon/77489
https://www.pharmacypracticenews.com/Online-First/Article/06-25/ACIP-Weakened-Judge-Orders-NIH-Grants-Restored/77491
https://www.pharmacypracticenews.com/FDA-News/Article/06-25/Yeztugo-FDA-Approved-HIV-PrEP/77492
https://www.pharmacypracticenews.com/Industry-News/Article/06-25/Camber-Pharmaceuticals-Announces-Availability-of-Chlorpromazine-HCl-Injection-USP/77514
https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/06-25/FDA-Approves-Monjuvi-for-Relapsed-or-Refractory-Follicular-Lymphoma/77518
https://www.pharmacypracticenews.com/Covid-19/Article/06-25/Mucormycosis-India-Mexico-Outbreaks-Covid-19/77530
https://www.pharmacypracticenews.com/Online-First/Article/06-25/Know-When-to-Hold-Continue-Medications-in-the-Perioperative-Period/77440
https://www.pharmacypracticenews.com/Review-Articles/Pain/Article/06-25/With-Progress-New-Challenges-Emerge-in-Medication-Administration-in-the-OR/77439
https://www.pharmacypracticenews.com/Policy/Infectious-Diseases/Article/07-25/ACIP-Delayed-Vaccination-Recommendations/77541
https://www.pharmacypracticenews.com/Multimedia/Medication-Safety/Article/07-25/ASHP-Pharmacy-Futures-Low-High-Level-Safety-Strategies/77544
https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/07-25/Datroway-Lung-Cancer-Treatment/77547
https://www.pharmacypracticenews.com/Monographs-and-Whitepapers/Article/07-25/Immune-Globulins/77551
https://www.pharmacypracticenews.com/Online-First/Infectious-Diseases/Article/07-25/acip-rsv-infants/77553
https://www.pharmacypracticenews.com/Multimedia/Article/07-25/DEI-HOPA-Access-Representation/77573
https://www.pharmacypracticenews.com/Policy/Article/07-25/thimerosal-ACIP-flu-shots/77574
https://www.pharmacypracticenews.com/Multimedia/Pain/Article/07-25/ASHP-Pharmacy-Futures-Chronic-Pain-Management/77576
https://www.pharmacypracticenews.com/Policy/Article/07-25/Keeping-an-Eye-on-New-Reimbursement-Trends/77534
https://www.pharmacypracticenews.com/Multimedia/Article/07-25/ASHP-2025-Pharmacy-Futures-Data-Integrity-Revenue-Cycle-Reimbursement-Payment-Insurance/77577
https://www.pharmacypracticenews.com/Clinical/Article/07-25/Pharmacist-Other-ID-Stakeholders-Slam-ACIP-Purge/77592
https://www.pharmacypracticenews.com/Clinical/Article/07-25/Optimizing-Ig-Therapy-Through-Certification-and-Competency/77597
https://www.pharmacypracticenews.com/FDA-News/Article/07-25/cefazolin-recall-sandoz-mispackaging/77608
https://www.pharmacypracticenews.com/Covid-19/Article/07-25/COVID-19-Impact-2025/77615
https://www.pharmacypracticenews.com/Multimedia/Article/07-25/ASHP-Pharmacy-Futures-Gaps-Barriers-USP-797/77633
https://www.pharmacypracticenews.com/Online-First/Article/07-25/RFK-Jr-Vaccine-Lawsuit-IDSA/77632
https://www.pharmacypracticenews.com/FDA-News/Hematology/Article/07-25/Lynozyfic-Approval-Multiple-Myeloma-Treatment/77643
https://www.pharmacypracticenews.com/Covid-19/Article/07-25/VYD2311-COVID-19-Antibody-Invivyd/77644
https://www.pharmacypracticenews.com/Multimedia/Article/07-25/Pharmacy-Medication-Reconciliation/77653
https://www.pharmacypracticenews.com/Online-First/Article/07-25/HHS-and-Private-Health-Insurers-Team-Up-to-Improve-Prior-Authorization-Process/77695
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/07-25/2-Tools-for-Assessing-the-Validity-of-Online-Content/77714
https://www.pharmacypracticenews.com/Operations-and-Management/Article/07-25/Why-are-Fewer-Pharmacy-Residents-Completing-Their-Training/77589
https://www.pharmacypracticenews.com/Policy/Article/07-25/DSCSA-Pharmaceutical-Supply-Chain-Enforcement/77602
https://www.pharmacypracticenews.com/Policy/Article/07-25/ASHP-Report-Some-Generic-Drugs-A-Persistent-Source-of-Rx-Shortages/77590
https://www.pharmacypracticenews.com/Online-First/Article/07-25/Gaps-and-Barriers-in-Sterile-Compounding-The-3-Ps/77728
https://www.pharmacypracticenews.com/Online-First/Article/07-25/5-Tips-for-Overseeing-Sterile-Compounding/77729
https://www.pharmacypracticenews.com/Online-First/Article/07-25/Choosing-the-Right-Agents-for-Sterile-Compounding-Cleanrooms/77730
https://www.pharmacypracticenews.com/Operations-and-Management/Article/07-25/New-Biosimilars-Metric-Confirms-Switching-Efficacy/77601
https://www.pharmacypracticenews.com/Clinical/Critical-Care/Article/07-25/Renin-Lactate-Levels-Key-to-Mortality-After-Refractory-Shock/77596
https://www.pharmacypracticenews.com/Clinical/Women’s-Health/Article/07-25/Diagnosing-and-Treating-Elusive-Postpartum-Psychosis/77598
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/07-25/Sterile-Compounding-Robot-Efficiency/77604
https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/07-25/Pediatric-Antimicrobial-Stewardship-Challenges/77595
https://www.pharmacypracticenews.com/Operations-and-Management/GI-Disorders/Article/07-25/FMT-May-Boost-Immunotherapy-Effectiveness/77600
https://www.pharmacypracticenews.com/Clinical/Medication-Safety/Article/07-25/Anticoagulation-Safe-For-Older-Adults-With-Careful-Monitoring/77591
https://www.pharmacypracticenews.com/Clinical/Nutrition/Article/07-25/4-Key-Categories-for-Managing-PN-Associated-Hyperglycemia/77593
https://www.pharmacypracticenews.com/Clinical/Nutrition/Article/07-25/Safe-Home-PN-Often-Hinges-on-Checking-Prescriber-Accuracy/77594
https://www.pharmacypracticenews.com/Clinical/Article/07-25/Elderly-Healthcare-System-Survey/77599
https://www.pharmacypracticenews.com/Industry-News/Article/07-25/Generic-Methadone-Hydrochloride-Injection/77779
https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/07-25/FDA-Imovax-Rabies-PrEP-expansion/77776
https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Nutrition/Article/07-25/AI-Streamlining-TPN-Infant-Nutrition/77603
https://www.pharmacypracticenews.com/Multimedia/Infectious-Diseases/Article/07-25/lenacapavir-broadly-neutralizing-antibodies-HIV-treatment/77777